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Abstract
Clamshell-like ligand binding domains (LBDs) are a diverse class of receptors present
in all clades of life. Ligands bind to a cleft which facilitates a transition from primar-
ily open conformations to closed conformations. The LBDs bind a diverse array of
ligands, and exhibit large conformational heterogeneity. This dissertation examines
the structure and conformational dynamics of three clamshell-like LBDs, each from a
different protein system: ionotropic glutamate receptors (iGluRs), metabotropic glu-
tamate receptors (mGluRs), and ionotropic receptors (IRs). In Chapter 1, I review
various clamshell-like LBD types and discuss their structure, function, and dynam-
ics. Chapter 2 introduces molecular dynamics simulation and contains a general
protocol for users to set up a similar system on their own. Chapter 3 reveals that
the iGluR GluK2, a kainate receptor, has remarkable conformational flexibility. We
also present agreement between theoretical and experimental results. Chapter 4
examines the conformational free energies of mGluR3 in monomer and dimer states,
and reveals an interesting effect of dimerization on the stability of closed state LBDs.
Finally, Chapter 5 discusses initial attempts to express and purify insect odorant
receptor IR LBDs. Together, this work advances our understanding of LBDs across
a spectrum of receptor families.
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Chapter 1 - Introduction to clamshell-like
ligand-binding domains
1
This dissertation examines structural and dynamical properties of clamshell-like
ligand-binding domains (LBD). Canonically, clamshell-like LBDs are two-state recep-
tors that transition from open to closed conformations in the presence of agonist. This
chapter introduces clamshell LBDs generally by way of periplasmic binding proteins,
and is followed by an introduction to the specific systems presented in later chapters:
1) ionotropic glutamate receptors, 2) metabotropic glutamate receptors, and 3) insect
ionotropic receptors.
1.1 Periplasmic binding proteins
Nutrient sensing is an essential activity for bacterial growth and survival. Gram neg-
ative bacteria accomplish this with periplasmic binding proteins (PBP) which couple
substrate binding to cellular uptake via inner membrane ABC transport proteins [1].
The PBPs constitute an ancient receptor superfamily, which bind chemically diverse
substrates such as amino acids, carbohydrates, ions, vitamins, and peptides [2,3]. The
binding and transport system is the largest functional group in the E coli genome,
consisting of at least 281 protein-coding genes [4, 5].
The 3D structure of a PBP was first solved in 1976 with the X-ray crystal structure
of the l-arabinose binding protein to 5 Å resolution [6]. In the subsequent 42 years,
over 100 PBP structures have been published [3], generating a wealth of insight into
PBP structure and conformational change. Structurally, PBPs are bilobed receptors,
with a substrate binding site at the lobe interface, and a hinge connecting the lobes.
In the absence of substrate, the PBPs adopt primarily open conformations. Many
PBPs, such as the ribose binding protein and the d-allose binding protein, appear
to adopt multiple, distinct open conformations in the apo state [2, 7–9]. In the pres-
ence of substrate, interactions between substrate and each of the two lobes triggers
a hinge bending motion and stabilizes a closed cleft conformation (Fig. 1-1). For
several PBPs, apo and substrate-bound proteins adopt both closed and open confor-
mations, and substrate binding merely shifts the equilibrium toward closed states [10],
suggesting the equilibrium between open and closed states is not all-or-none in apo
and ligand-bound forms. The open-to-close transitions of bi-lobed receptors have
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drawn comparisons to the hinge motion of clamshells [11] and Venus flytraps [1, 12].
Despite the chemical diversity of PBP substrates and low sequence similarity
between subtypes, PBPs only adopt one of two general folds [3, 4], referred to as
Class I and Class II (Fig. 1-2). There are two key structural features that separate
Class I from Class II PBPs. One, Class I PBPs typically have at least twelve conserved
beta strands (A-L) that occupy equivalent positions in structures, whereas Class II
PBPs have only 10 (A-J) conserved beta strands. Also, the J beta strand in Class I
PBPs is located in the top lobe, but has been relocated to the bottom lobe in Class
II PBPs [4]. These two classes descend from a common ancestor. Class I PBPs most
closely resemble the hypothesized progenitor PBP [4]. The architecture for Class I
and Class II PBPs is also observed in bacterial cytoplasmic DNA-binding regulatory
proteins (e.g. LacI). In eukaryotes, Class I and II PBPs underwent separate gene
fusion events with membrane proteins to form functional membrane receptors, where
the PBPs now serve as ligand-binding domains (LBDs), e.g. ionotropic glutamate
receptors (iGluRs) [13, 14] and Class C GPCRs (e.g. metabotropic glutamate and
GABA-B receptors) [12,15]. Specifically, the folds of Class C GPCR LBDs and iGluR
amino terminal domains descend from Class I PBPs, whereas iGluR LBDs descend
from Class I PBPs. The functional diversity of clamshell-like binding domains has
made them desirable targets for engineering of biosensors [16,17], novel enzymes [18],
and optogenetic tools [19] that have been used to restore a visual response in blind
mice [20].
1.2 Ionotropic glutamate receptors
1.2.1 iGluR function
Ionotropic glutamate receptors (iGluRs) are tetrameric ligand-gated ion channels clas-
sified primarily into four pharmacologically-derived sub-families: kainate, N-methyl-
d-aspartate (NMDA), 𝛼-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA),
and 𝛿 [21]. These families are further classified into specific subtypes. In humans,
these are GluA1-4 AMPA receptors, GluK1-5 kainate receptors, GluN1, GluN2A-D,
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GluN3A-B NMDA receptors, and GluRD1,2 receptors. In mammals, iGluRs medi-
ate excitatory neurotransmission at synapses by directly depolarizing post-synaptic
neurons in response to neurotransmitter binding [22]. Free glutamate is packaged
into vesicles in pre-synaptic neurons, which undergo calcium-dependent exocytosis
and release glutamate into the synaptic cleft, resulting in a large increase of synap-
tic glutamate concentration [23]. Glutamate diffuses across the synaptic cleft and
binds iGluRs, which undergo a series of concerted conformational transitions to trig-
ger the opening of the ion channel pore. Na+, K+ and sometimes Ca2+ cations move
through the open pore from the extracellular space into the cell, causing cell depo-
larization [24]. An action potential is triggered in the post-synaptic neuron if the
membrane potential crosses a threshold [25].
Glutamate is the most abundant amino acid in the central nervous system, and
is excitatory at over 90% of synapses [26, 27]. Proper iGluR function is required
for several higher order cognitive processes such as learning and memory, and its
dysfunction has been linked to several neurological disorders, like schizophrenia [28].
Outside the central nervous system, there is iGluR expression in peripheral organs
like the pancreas, where AMPA receptors stimulate the release of glucagon [29, 30],
and the kidneys, where NMDA receptors contribute to the function of the glomerulus
[31]. Broad iGluR expression and functionality throughout the body make iGluRs
an attractive pharmacological target for treating disease. They are also an ancient
receptor family, and play important physiological roles in many clades of life. For
instance, in the plant Arabidopsis thaliana, GLUTAMATE RECEPTOR-LIKE genes
were found to mediate wound signaling between leaves [32]. To date, iGluRs have been
characterized in insects [33], ctenophores [34], bdelloid rotifers [13], and prokaryotic
cyanobacteria [35].
1.2.2 iGluR Domains
Structurally, eukaryotic iGluRs are composed of four modular domains: the amino-
terminal domain (ATD), the ligand-binding domain (LBD), the transmembrane do-
main (TMD), and the C-terminal domain (CTD) [36]. The ATD is a clamshell that
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closely resembles Class I PBPs and Class C GPCR LBDs. The function(s) of the
ATDs is relatively unknown and remains the focus of intense research. In NMDA
receptors, the ATDs are known to affect the open probability of the ion channel, and
act as sites of allosteric regulation by binding molecules in the clamshell cleft [37].
It has been suggested that NMDA ATDs are more susceptible to allosteric modula-
tion than the ATDs of other subtypes because of looser packing between the ATD
lower lobes, allowing conformational flexibility and facilitating ATD clamshells to
open and close. Additionally, NMDA ATDs are positioned closer to the LBD layer
than in AMPA receptors, possibly allowing stronger allosteric communication to be
communicated between the ATD and LBD layers in NMDA receptors [38–40]. In
non-NMDA receptors, the ATD appears to play a less significant role in altering open
channel probabilities, and have a reduced capacity to bind allosteric regulators. This
is perhaps due to decreased flexibility of the clamshell cleft, restricted inter-ATD
subunit movement, and/or the relatively long linker between the ATD and LBD
layer [41]. Recent work has challenged this framework, however. AMPAR ATDs have
been shown to possess more conformational flexibility than previously thought, and
recent structures depict closer ATD-LBD contact than was present in older struc-
tures suggesting the possibility of allostery in AMPAR ATDs [42, 43]. Isolated ATD
domains are structurally well-characterized by X-ray crystallography. There are sev-
eral crystal structures of isolated iGluR ATD for various subtypes, both as homo-
mers (GluA1 [44], GluA2 [45–47], GluA3 [48], GluA4 [43], GluK2 [49], GluK3 [50],
GluK5 [50], GluN1 [51, 52], GluN2B [53], GluD1 and GluD2 [54]), and heteromers
(GluK2/GluK5 [55], GluN1/GluN2A [56], GluN1/GluN2B [57]). The interface of
ATD dimers is reminiscent of mGluR LBD dimers (see Fig. 4-5).
The LBDs bind substrate and directly control ion channel pore opening [58].
The LBDs resemble Class II PBPs and are the focus of hundreds of functional and
structural studies. Agonist-bound LBD conformations associated with ion chan-
nel activation adopt fully-closed conformations, partial agonists primarily induce
partially-closed LBD conformations, and apo and antagonist bound LBDs are typ-
ically open [59]. The relationship between LBD closure and agonism is routinely
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observed in the over 300 crystal structures corresponding to full agonism, partial ag-
onism, antagonism, and apo states. There are exceptions to this rule (e.g. the closed
cleft of apo GluN3A in [60]), suggesting iGluRs possess conformational flexibility.
This dynamic flexibility has been corroborated by a wealth of experimental and com-
putational approaches, including single molecule FRET [61], NMR [62], and molecular
dynamics simulation [63]. These approaches have also generated deeper insights into
LBD conformational dynamics, channel gating, the thermodynamics of ligand binding
and clamshell closure [59], and ligand-binding pathways and kinetics [64,65].
The majority of iGluR subtypes has an associated crystal structure of its LBD, and
occasionally as a homo- or heterodimer, representing a large variety of conformational
states: GluA2 ( [66–69]), GluA3 ( [70,70]), GluA4 ( [71]), GluK1 ( [67,72–74]), GluK2
( [75]), GluK3 ( [75,76]), GluK4 ( [77]), GluN1 ( [60]), GluN2A ( [78]), GluN3A ( [60]),
and GluD1 ( [79]).
The iGluR TMDs share a common ancestor with K+ channels; all iGluRs likely
descend from a gene fusion event between a class II PBP and a K+ channel [13]. Some
non-animal iGluRs retain K+ selectivity, e.g. GluR0 and AvGluR [13]. Each subunit
has four helices (M1-M4), with a re-entrant loop between helices 2 and 3 that contains
the selectivity filter, but is topologically inverted compared to K+ channels [80].
In GluA2, the glutamine to arginine (Q/R) mRNA modification in the re-entrant
loop reduces selectivity for calcium [58]. The M3 helix of each subunit forms the
ion channel pore, and is directly tethered to the LBD lower lobe [81]. The M4
helix is absent in prokaryotic iGluRs and is important for subunit assembly and
trafficking [82].
The CTD is cytoplasmic and responsible for regulating receptor trafficking, long-
term potentiation, and channel open probability [58]. These functions are frequently
mediated by differential phosphorylation of the CTD [83]. There is considerable
variability in CTD length between iGluR subtypes and splicing variants, and the
precise roles of the CTD still remain to be resolved. Structurally, CTDs are thought
to be mostly intrinsically disordered, and to date there are no 3D structures of any
iGluR CTD. Nonetheless, active efforts in this area seek to solve structures of CTDs
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in complex with other proteins, where CTDs (or CTD sub-regions) are likely to take
on preferred configurations.
1.2.3 Tetrameric assembly
NMDA receptors are obligate heterotetramers composed of glutamate-binding GluN2
subunits and glycine-binding GluN1 or GluN3 subunits [84]. AMPA and kainate re-
ceptors bind glutamate and form functional homo- and heterotetramers [58]. Three
major receptor functional states are observed in electrophysiology: the resting state,
active state, and desensitized state (corresponding to a closed channel in the presence
of agonist). Each functional state is associated with a set of conformations of the
tetramer [58]. Solving the structure of native iGluRs in the active, inactive, and de-
sensitized states is significantly more challenging than isolated domains. Challenges
here include the relative difficulty of crystallizing membrane proteins and the tran-
sient conformational states associated primarily with activated states, but also other
functional states.
Nevertheless, several native iGluR structures have been publish in the past few
years. The first structure of a tetrameric iGluR assembly was that of the AMPA
receptor GluA2 homotetramer with a closed ion channel pore, and an antagonist
bound to the LBD cleft, likely representing an inactive conformation [81]. The
tetrameric assembly of this structure adopts a characteristic "Y" shape (Fig. 1-3
left). Subsequent AMPA structures depict pre-open, open, and desensitized confor-
mations [42,85,86]. Notably, whereas homomeric inactive GluA2 has a characteristic
"Y" shape with significant separation between LBD and ATD layers, the heteromeric
inactive GluA2/GluA3 has a much more vertically condensed structure. This opens
up the possibility of enhanced allosteric signaling between the ATD and LBD of
AMPA heteromers [58]. Structures associated with each of the functional states of
the GluA2 homotetramer are shown in Fig. 1-5A. Ion channel pore opening appears
to be triggered by 1) closure of LBDs, and 2) tilting of the A and C LBD subunits
away from the B and D subunits (Fig. 1-5B). Structures of the GluA2 desensitized
state demonstrate conformational heterogeneity and often substantial disruption of
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dimer-of-dimer contact in the ATD and LBD layers [86]. This substantial separation
is not always present, however [87, 88]. Recent analysis suggests ATD splaying in
desensitization could be an artifact of construct design and/or sample preparation,
and is unlikely to occur in vivo because of crowding [89].
Structures of native NMDA and kainate receptors have also been solved in vari-
ous conformational states [39, 86, 90–92]. Fig. 1-3 depicts representative structures
of native iGluRs from the AMPA (GluA2), NMDA (GluN1/GluN2A), and Kainate
(GluK2) families. The GluA2 and GluN1/GluN2B depicted are inactive assemblies.
Both tetramers are globally two-fold symmetric but each layer of the tetramer has
distinct symmetry and subunit pairing (see Fig. 1-4). The TMD layer is four-fold
symmetric in GluA2 and pseudo-four-fold symmetric in GluN1/GluN2B. The LBD
layer is a two-fold symmetric dimer-of-dimers where the A/D subunits form one dimer
and B/C form the other. The A and C subunits and B and D subunits are equivalent
within the LBD layer, respectively. In GluN2B, the 1-𝛽/2B-𝛼 forms one dimer, and
2B-𝛽/1-𝛼 form the other; 1-𝛼 and 1-𝛽 subunits and 2B-𝛼 and 2B-𝛽 are equivalent.
The ATD layer has a similar arrangement to the LBD layer, except for a domain
dimer partner swap: B/A and C/D are dimer partners in the GluA2 ATD layer, and
2B-𝛽/1-𝛽 and 1-𝛼/2B-𝛼 are partners in the GluN1/GluN2A ATD layer. In contrast
to GluA2 and GluN1/GluN2B, the GluK2 structure shown likely represents a desen-
sitized state. The principal difference is a two-fold to four-fold symmetry transition
in the LBD layer. The LBD dimer interfaces are completely disrupted, and the top
lobes of the LBDs are oriented outward from the center of the receptor.
1.3 Class C GPCR Ligand binding domains
G-protein coupled receptors (GPCRs) are seven-pass transmembrane receptors that
couple extracellular ligand binding to intracellular signaling. Ligand binding triggers
a conformational transition that activates guanine exchange factor (GEF) activity
which promotes GTP exchange and dissociation of a trimeric G protein from the
GPCR. The G protein subunits (𝛼 and 𝛽𝛾) in turn activate downstream effector pro-
teins (e.g. Adenylyl cyclase) (Fig. 1-6). The GPCRs are a large receptor superfamily,
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consisting of over 800 genes in humans, or ∼4% of the human protein-coding genome.
These genes are further clustered into five classes A-F, which are structurally similar
but share <20% sequence identity [93]. Functionally, GPCRs serve in a wide variety
of systems: vision, olfaction, gustation, neuronal, and hormone signaling [93]. As
such, GPCRs are also the most common drug target: ∼34% of all FDA approved
drugs target GPCRs (475 FDA-approved drugs target GPCRs as of July 2017) [94].
The transmembrane domains of GPCRs are relatively well-characterized struc-
turally. To date, there are over 50 atomic structures of unique GPCR proteins, and
over 200 atomic structures in total [95]. These studies have yielded invaluable insight
into GPCR structure and conformational change. However, most of these structures
have removed domains and flexible loops outside the membrane. For example, Class
C GPCRs are distinguished by large N-terminal clamshell LBDs that are absent in
structures with the TMD, and vice versa. The metabotropic glutamate receptors
belong to the Class C GPCRs, and while there are separate structures of mGluR
TMDs ( [96–98]) and the LBDs ( [99–104]), there are no structures with both do-
mains present.
Class C GPCRs are obligate dimers, with dimer interfaces between both the LBD
and TMD domains of each subunit (Fig. 1-7, top). There is also a cysteine rich
domain (CRD) between the LBD and TMD. Receptors in this class include calcium-
sensing, GABAB , mGluR, RAIG, and taste. Activation of Class C receptors involves
ligand binding and LBD closure, which triggers a rotation of the dimer interface
(Fig. 1-7, bottom). The reorientation of the LBD dimer interface is signaled to the
TMDs, which trigger downstream events. The inactive state of the LBD dimer is
associated with open LBDs, and a dimer interface with separated lower lobes. When
agonist binds to the LBD cleft, cleft closure stabilizes the dimer interface rotation to
a state where the lower lobes form a dimer interface. In the presence and absence of
agonist, LBDs rapidly oscillate between active and inactive conformations. Agonists
merely shift the equilibrium such that the receptor has a higher probability of visiting
the active conformation. Activation at the LBD layer is presumably transmitted to
the TMD layer via the CSD. Re-orientation brings the CSD of each subunit into close
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proximity, and introducing cysteine locks between CSDs results in a constitutively
active receptor. A re-orientation of the dimer interface at the TMD layer is also
required for G protein activation.
1.4 Insect ionotropic receptors
A universal property of life is the ability to sense external chemical species. This allows
lifeforms to find food, suitable mates, and avoid danger. Whereas mammalian sensory
receptors for external chemical stimuli are typically GPCRs, insects primarily utilize
ion channels instead [105]. This difference could represent evolutionary happenstance,
or reflect the importance of insect reaction time, where signal speed is selected over
signal amplification [105]. Chemosensation in insects is divided between olfactory
receptors (ORs), pickpocket ion channels (PPKs), transient receptor potential ion
channels (TRPs), gustatory receptors (GRs), and ionotropic receptors (IRs) [106].
The ORs and GRs are seven transmembrane ionotropic receptors, and are unrelated to
the seven transmembrane GPCRs [107]. Ppks are sodium channels required for water
sensing, and TRP channels are six-pass ion channels responsible for thermosensation,
the detection of electrophilic compounds, as well as some bitter compounds [108].
The IRs represent a newly characterized class of receptors, with homology to the
ionotropic glutamate receptors, but cannot be classified into the NMDA, AMPA, or
kainate families [109]. The IRs are a divergent receptor family, composed of over
60 subtypes in Drosophila, with 10-70% amino acid sequence identity shared between
subunits globally. Compared to the rest of the protein, the LBD region is significantly
less conserved on average (<34% shared identity). The putative ligand-binding site
lacks conserved residues found in iGluR LBDs, for example, only 31% of IRs possess
the 𝛼-carboxy-binding l-arginine residue conserved in all iGluRs. The sequence di-
vergence is also reflected in the diversity of ordorants that bind IRs. Despite the large
number of odorants recognized by IRs, the types of odorants are limited largely to
amines, carboxylic acids, and aldehydes [106, 110–114], reflecting their similarity to
iGluRs which bind amino acids. The majority of IRs are expressed in odorant sen-
sory neurons, and are directly responsible for sensing odorants. However, there are
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exceptions that suggest IRs play roles outside odorant recognition: IR21 and IR25a
are required for cold avoidance [115], where IR25a’s temperature sensing role also
controls the circadian clock [116]; IR64, IR40a, and IR93a play important roles in
humidity sensing [117, 118]. IR20a has been proposed to be a taste and pheromone
receptor [119]. IRs are of particular interest for the development of novel insect re-
pellents; initially, IR40a was proposed to act as a DEET receptor, however, recent
work suggests otherwise [120]. The mechanism of DEET detection in insects remains
unresolved.
IRs are thought to be tetrameric ion channels like iGluRs [121]. IR subunits
are classified as either odor-specific or co-receptors. Odor-specific IR subunits are
selectively expressed in sensory neurons and are responsible for odor recognition. Co-
receptor subunits (i.e. IR8a and IR25a) are broadly expressed and required for proper
channel assembly, trafficking, and activation [121]. Notably, while odor-specific pos-
sess LBDs and TMDs that are related to their iGluR counterparts, their N-terminal
regions are unrelated to iGluR ATDs. The co-receptors IR8a and IR25a, however,
do have canonical iGluR ATDs (Fig. 1-8, left). In vivo results from a fluorescently-
tagged IR84a odor-specific subunit and IR8a co-receptor subunit indicated the sto-
ichiometry in tetrameric assemblies is two co-receptor subunits to two odor-specific
receptors, but it is unclear whether this generalizes to all IRs [121]. The proposed ar-
rangement of subunits in the tetrameric assembly shown in Fig. 1-8 (based on Figure
2B in [114]) was chosen to allow the co-receptor ATDs to occupy the proximal ATD
position, where they are able to interact, as opposed to the distal position, where
they would not. The model depicted in Fig. 1-8 is based on the NMDA receptor.
To date, no 3D structural information exists for IRs. Solving the structures of
isolated IR ligand-binding domains, amino-terminal domains, and not to mention
fully assembled receptors, are necessary to understand the molecular basis of odor
recognition and the molecular evolution of iGluRs.
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1.5 Overview of remainder of thesis
The remainder of this dissertation presents the conformational and dynamical prop-
erties of various clamshell-like LBDs, using both computational and experimental
approaches.
Chapter 2 introduces the computational method of molecular dynamics simula-
tion on LBDs presented in Chapters 3 and 4. The chapter begins as an introduction
to the principles of molecular dynamics simulation and umbrella sampling, and ends
with a practical discussion of how to implement the system.
Chapter 3 presents the energetics of LBD conformational transition in a kainate
receptor LBD. Conformational free energy calculations show that apo GluK2 is re-
markably flexible. Calculations with disrupted interdomain contacts suggest that
residues contribute variably to closed state stability. Comparison of experimental
and theoretical SAXS show remarkable agreement, which are a significant improve-
ment over predictions from the crystal structure alone. Finally, we present the first
structural characterization of apo GluK2.
Chapter 4 examines the energetics of both monomeric and dimeric mGluR LBDs.
Monomeric glutamate-bound mGluR3 exhibits two-state character, but interestingly
dimerization to a closed-state LBD partner appears to stabilize closed state confor-
mations. Additionally, the energetics of the LBD dimer interface are examined.
Chapter 5 contains a summary of attempts to experimentally characterize IR
LBDs. This covers construct design of various IR subtypes LBDs and expression
attempts in both bacterial and baculovirus insect cell system. In brief, isolated IR
LBDs appear to be substantially more challenging to express than their iGluR coun-
terparts, although some promising leads were discovered. It is possible iGluR guide-
posts are misleading, and future studies should potentially re-visit construct design
from scratch.
12
Fig. 1-1: Ligand binding and clamshell closure in periplasmic binding pro-
teins. Depiction of the glutamine binding protein transitioning from an apo, open
state (left, PDB: 1GGG) to a glutamine-bound, closed state (right, PDB: 1WDN).
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Fig. 1-2: Structure of class I and II periplasmic binding proteins. Left : l-
Arabinose-binding periplasmic protein (PDB: 8ABP), with l-arabinose shown in the
binding cleft with VDW representation. Right : Histidine-binding periplasmic protein
(PDB: 1HSL), with histidine shown in the binding cleft with VDW representation.
The architecture of Class I PBPs is also observed in eukaryotic Class C GPCR ligand-
binding domains (e.g. mGluRs), as well as iGluR amino terminal domains. The
architecture of Class II PBPs resembles the iGluR ligand-binding domains.
14
Fig. 1-3: Ionotropic glutamate receptors. Left : AMPA receptor homotetramer
GluA2 bound to antagonist. Center: Kainate receptor homodimer GluK2 bound
to agonist, possibly in desensitized conformation. Right : NMDA receptor heterote-
tramer GluN1/GluN2B bound to agonists glycine/glutamate, respectively, in LBD
cleft and GluN2B allosteric inhibitor ifenprodil in the ATD.
15
Fig. 1-4: Symmetry and structural arrangement of iGluR tetramers. Ar-
rangement of subunits in full-length structures of AMPA GluA2 (left), Kainate GluK2
(center), and NMDA GluN1/GluN2B (right). For GluA2 and GluN1/GluN2B, the
crystal structures likely represent inactive states, where the TMDs have either four-
fold (GluA2) or pseudo four-fold (GluN1/GluN2B) symmetry, the LBD layer is a
two-fold symmetric dimer-of-dimers. Dimer partners are the A/D and B/C subunits
in GluA2, and the 1-𝛽/2B-𝛼 and 2B-𝛽/1-𝛼 subunits in GluN1/GluN2B. The ATD
layer is also a two-fold symmetric dimer-of-dimers but with a domain swap from the
LBD layer. Dimer partners in the ATD layer are the B/A and C/D subunits in
GluA2 and the 2B-𝛽/1-𝛽 1-𝛼/2B-𝛼 subunits in GluN1/GluN2B. The arrangement of
subunits in GluK2 likely represents a desensitized state, where the TMD and ATD
layers maintain the same symmetries seen in NMDA and AMPA receptors, but dis-
rupted dimer interfaces in the LBD layer cause four-fold symmetry instead of two-fold
symmetry.
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Fig. 1-5: Functional states of AMPA receptors. A. Views of the inactive, ac-
tive, and desensitized states of GluA2. The inactive state has a characteristic "Y"
shape, the active state looks broadly similar but has a bulging pore, and the desensi-
tized states exhibit a large variety of conformational heterogeneity characterized by
symmetry breaking in the extracellular domains, and large-scale separation of the
ECDs. B. Cartoon depiction of changes in the LBD layer associated with activation.
In the inactive LBD orientation left, both LBDs are open and the subunit on the right
is at a slight angle to the one on the left. In the transition to the active state right,
both LBDs close in response to agonist binding, and the subunit on the right under-
goes a rotation with respect to the subunit subunit on the left, where the bottom-top
axis of the subunit on the right becomes more perpendicular to the bottom-top axis
of the subunit on the left.
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Fig. 1-6: GPCR activation. left Inactive GPCR (yellow) bound to trimeric G
protein (G𝛼𝛽𝛾). When ligand (red) binds to GPCR, it triggers a conformational
change that activates guanine exchange factor (GEF) to exchange out GDP for GTP
and promote dissociation of G protein from the GPCR. The G𝛼 and G𝛽𝛾 subunits
separate and are free to activate effector proteins.
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Fig. 1-7: Structure and activation of metabotropic glutamate receptors.
Top, Structural model of a full length mGluR dimer. Bottom, Simple model of mGluR
activation. Glutamate (red), binds LBDs, which induces cleft closure, and a reorienta-
tion of the dimer interface. The CRDs come into close proximity, which is signaled to
the TMD which undergoes a conformational transition, which signals to downstream
processes.
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Fig. 1-8: Structural model of IR tetramer assembly. Model built using NMDA
GluN1/N2B as reference (PDB: 4PE5). Left, Co-receptor subunit (e.g. IR8a) with
intact ATD. Center, odor-specific subunit (e.g. IR84a), lacking an ATD. Right, fully
assembled tetramer. Co-receptor subunit situated so the ATDs occupy proximal
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Ionotropic glutamate receptors (iGluRs) transduce chemical signals at synapses
into electrical impulses. This function relies on concerted conformational changes that
are propagated among the linked domains of the tetrameric protein assembly making
up each receptor. A key conformational change is the closure of the ligand-binding
domain (LBD) upon agonist binding, which eventually gates the transmembrane ion
channel domain. The free energy that becomes available for gating transitions is gov-
erned by the LBD free energy landscapes for apo and ligand-bound states. These
landscapes describe the thermodynamic equilibrium among various LBD conforma-
tions. Delineating these landscapes is essential for understanding the molecular driv-
ing forces underlying iGluR function. Molecular dynamics free energy simulations
offer a means for estimating these quantities, which are difficult to extract from ex-
perimental results alone. Here, we describe the process of carrying out a free energy
computation using an umbrella sampling strategy for characterizing large-scale con-
formational changes in iGluR LBDs.
2.1 Background
Structural studies of ionotropic glutamate receptors (iGluRs) have provided valuable
insights into the molecular mechanics of activation and desensitization [1]. These
studies have helped characterize the conformational changes that take place within
an isolated ligand-binding domain (LBD) upon binding of agonists and antagonists
in addition to the molecular rearrangements that are associated with desensitization.
The numerous crystal structures of isolated iGluR domains and intact iGluR recep-
tors also provide atomistic models that enable molecular simulation studies. Such
studies allow one to probe conformational energetics not easily accessed by experi-
mental approaches alone by, for example, considering conformational states that are
transient, not heavily populated, or refractory to crystallization. Such considerations
are important for understanding iGluRs, which are allosteric receptors that rely on
complex molecular dynamics for executing their function.
Straightforward, unbiased molecular dynamics (MD) simulations have shed light
on important dynamic events involving the LBD; for example, by suggesting pos-
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sible pathways for conformational changes related to receptor activation [2, 3] and
rearrangements in the configuration of waters in the binding cleft [4]. While these
types of simulations are useful, they can have limitations when applied to complex
macromolecular systems that exhibit significant conformational changes. Instead,
one can employ a simulation strategy that generates a "free energy landscape", or
equivalently, a "potential of mean force" (PMF), along specifically chosen coordinates
to obtain a reduced description of conformational changes in the system. The free
energy difference between conformational states reflects the probability of finding the
system in those states.
This chapter focuses on the computation of free energy landscapes using umbrella
sampling MD simulations. The systems of interest here are iGluR LBDs. Due to
space constraints, we limit the discussion of numerous general aspects of setting up
and carrying out an MD simulation. These topics, however, are covered elsewhere
in excellent overviews, e.g., by Cheng and Ivanov [5] and the NAMD tutorials at
www.ks.uiuc.edu/Training/Tutorials/namd-index.html. The theory of umbrella sam-
pling is discussed in some detail for the sake of completeness and because of its
practical utility, as it provides a guide for writing the computer code necessary for
carrying out the calculations. We hope that this chapter will be useful to readers in
facilitating computational studies of iGluR conformational energetics.
2.2 Materials
The most widely used molecular dynamics (MD) simulation packages for biomolecules
are CHARMM [6], AMBER [7], GROMOS [8], NAMD [9], and GROMACS [10].
CHARMM and AMBER have been in continuous development for the longest, offer
advanced sampling and analysis capabilities, and are associated with their own force
fields for proteins, nucleic acids, lipids, and carbohydrates [5]. All LBD umbrella sam-
pling simulations described below were performed using CHARMM, although other
packages can be used as well. NAMD and GROMACS have been developed to excel
in performance (i.e., computational speed), and they support numerous force fields.
The package Desmond [11], from D.E. Shaw Research, also offers high performance
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and supports multiple force fields. For a comparison of different force fields, see a
review by Guvench and MacKerell [12]. VMD [13] is a widely used molecular graphics
program for structure and trajectory analysis.
MD packages generally require an operating system based on Unix/Linux. Some
aspects of setting up a simulation system may be accomplished on a workstation, but
equilibration and production simulations are typically performed on either commod-
ity computing clusters containing many processors or high-end computing platforms
available through resources such as the Extreme Science and Engineering Discovery
Environment (XSEDE; www.xsede.org).
2.3 Methods
2.3.1 Molecular Dynamics Simulations
At the heart of a molecular mechanics simulation is the potential energy function
that relates the atomic coordinates of a system, R, to the energy, 𝑈 [14] (Fig. 2-1).
































where the equilibrium values for the bond distance, b, the valence angle, 𝜃, and
the improper dihedral angle (to maintain chiral and planar centers), 𝜒, are 𝑏0, 𝜃0, and
𝜒0, respectively; the multiplicity and phase for the dihedral angle, 𝜑, are 𝑛 and 𝛿; 𝑞𝑖
and 𝑞𝑗 are the partial atomic charges on atoms i and j; the K s are the force constants;
𝜖 is the dielectric constant; 𝑟𝑖𝑗 is the distance between atoms i and j; and the Lennard-
Jones potential well depth and minimum interaction radius are 𝜖𝑖𝑗 and 𝑅min,𝑖𝑗. The
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"bonded" terms are the bonds, angles, dihedrals, and improper dihedrals; the "non-
bonded" terms are the electrostatic interactions treated using a Coulombic term and
the interatomic repulsion and dispersion interactions treated using a Lennard-Jones
"6-12" term. These terms are common to most modern biomolecular force fields,
including CHARMM, AMBER, GROMOS, and OPLS [15], among others. To in-
crease the accuracy of force fields, additional or alternate energy terms have been
incorporated. An example of an additional term is the two-dimensional dihedral en-
ergy grid "correction map" (CMAP) applied to protein backbone 𝜑 and 𝜓 angles
in CHARMM [16]. Other examples are described in a review by MacKerell [14].
Once 𝑈(R) is defined, the time evolution of a system of atoms may be obtained by
integrating Newton’s equations of motion,
𝐹 (R(𝑡)) = −∇𝑈(R(𝑡)) =𝑀R̈(𝑡) (2.2)
where 𝑡 is time, 𝐹 is the ensemble of forces on the atoms, ∇𝑈 is the gradient of the
potential, 𝑀 is the matrix that specifies the mass of every atom, and R̈ is the second
derivative of the atomic coordinates with respect to time. Combining Taylor series
expansions for R(𝑡+𝛿𝑡) and R(𝑡−𝛿𝑡) yield the Verlet integration algorithm, which is
used to generate the dynamical trajectory of the system. Details concerning the prop-
agation of atomic velocities and positions, as well as many practical considerations
regarding MD simulations, are covered in a review by Cheng and Ivanov [5].
2.3.2 Order Parameters
How might one go about computing the change in free energy for a conformational
transition in a system? A first step would be to identify a continuous coordinate 𝜉,
also referred to as an order parameter, which is a function of a few or more degrees of
freedom in the system, and traverses the system’s conformational states of interest.
Order parameters along the most important degrees of freedom are often chosen as
a reduced descriptor of the system. Any choice of order parameter is possible, such
as a distance, an angle, or a root mean square deviation from a reference state. The
order parameter may be multidimensional, e.g., two distances or a distance plus an
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angle. Choosing an appropriate order parameter for a given system often requires a
mix of physical intuition and prior knowledge of the chemical process under consider-
ation. Several novel strategies have been developed to quantitatively determine order
parameters [17]. These techniques include combining MD simulations with either
principal component analysis (PCA) or a determination of the atomic fluctuations
that correspond to the largest amounts of information transfer in a conformational
transition. Normal mode analysis (NMA) has also been suggested as a means for
identifying the most important collective motions [18–20].
2.3.3 Umbrella Sampling
Once the order parameter, 𝜉, is chosen, the average distribution function along 𝜉 can






where 𝑈(r) is the energy of the system as a function of the atomic coordinates r,
𝛿[·] is the Dirac delta function, 𝑘𝐵 is Boltzmann’s constant, and 𝑇 is temperature.
The free energy, or PMF, 𝑊 (𝜉), along 𝜉 can be computed as follows:





where 𝜉′ is an arbitrary reference value. In principle, 𝑊 (𝜉) could be computed di-
rectly from a "brute force" molecular dynamics simulation of the system. In practice,
however, this approach is often limited because large free energy barriers along 𝜉 can
impede the amount of conformational space that is sampled within an allotted sim-
ulation time (Fig. 2-2). Poor sampling would yield unreliable statistics from which
to calculate free energy differences. Consequently, numerous sampling strategies have
been developed to more effectively calculate a PMF from molecular dynamics simula-
tion trajectories. One of these strategies is the umbrella sampling method developed
by Torrie and Valleau [23]. This method typically involves carrying out multiple
independent simulations, where each simulation takes place in the presence of an
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applied potential, 𝑤(𝜉). This artificial bias for each simulation, or window, confines
sampling to a region near a chosen value of 𝜉. The chosen 𝜉 is different for each
window. A convenient form for the artificial bias in the ith window is a harmonic
function, i.e., 𝑤𝑖 = 12𝐾(𝜉 − 𝜉𝑖)2, where K is the force constant. The set of 𝜉𝑖 spans
the conformational space of interest.
A biased distribution function is generated by each window. The process of unbi-
asing and recombining the results of sampling in all the windows in order to obtain
𝑊 (𝜉) involves calculating the free energy associated with introducing the window po-
tential. Numerous approaches have been developed to accomplish this task [21–24].
We will discuss only one of these approaches, the weighted histogram analysis method
(WHAM) [25], although other valid approaches are available. Essentially, the WHAM
estimates the unbiased distribution function by computing a weighted sum of all the
sampling data and determining the functional form of the weight factors that mini-
mizes the statistical error [21,25,26].
Briefly, WHAM uses two equations, known as the WHAM equations, to compute
the unbiased distribution and potential of mean force. The first equation is for the












where [⟨𝜌(𝜉)⟩](𝑖),unbiased are the individual unbiased distribution functions, and 𝑛𝑖
are the number of sampling data points used to generate each biased distribution
function.




These two equations are interdependent (i.e., 2.5 requires ⟨𝜌(𝜉)⟩ and 2.6 requires
𝐹𝑖) and are therefore solved in a self-consistent manner via an iterative procedure.
First, an estimate for the unbiased distribution ⟨𝜌(𝜉)⟩ is computed using an initial
guess for all of the 𝐹𝑗. Next, 𝑒−𝐹𝑖(𝜉)/𝑘𝐵𝑇 is evaluated using the estimate for ⟨𝜌(𝜉)⟩. The
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cycle is repeated using the new estimates for 𝐹𝑗 until both equations have converged.
The equations above are written in terms of a one-dimensional 𝜉. The approach can
be applied to multidimensional scenarios as well. For example, the WHAM equations
can be reformulated for handling a two-dimensional order parameter involving the
variables 𝜉1 and 𝜉2.
Additional theoretical details and derivations may be found in Souaille and Roux
[27]. Generic computer code for carrying out WHAM calculations is also provided in
this reference. The first PMFs computed for an iGluR LBD involved the GluA2 S1S2
construct [28]. The umbrella sampling simulations generating the PMFs employed
a two-dimensional order parameter consisting of two distances between the lobes of
the LBD (Fig. 2-3). The order parameter was inspired by the observation that the
distances between T480 and S654, and between E402 and T686 each differ by ∼3.5
Å when comparing crystal structures of apo and agonist-bound LBDs [29]. Each pair
of residues is hydrogen bonded in the agonist-bound structures but not in the apo
structure. In the order parameter (𝜉1, 𝜉2), 𝜉1 is the distance between the centers of
mass (COM) of residues 479-481 in lobe 1 and residues 654-655 in lobe 2, and 𝜉2
is the distance between the COM of residues 401-403 in lobe 1 and residues 686-
687 in lobe 2. These residues correspond to regions that are not in flexible loops.
All non-hydrogen atoms were included in the selections. The rationale for using
multiple residues in the definitions of 𝜉1 and 𝜉2 was to increase the likelihood that
changes in the COM distances would represent large-scale conformational changes
rather than fluctuations in individual residues. We should note that we initially
attempted to define an angle to monitor opening and closing of the LBD, in a fashion
similar to how the crystal structures were characterized. However, we found this
order parameter behaved poorly and is ill-suited for use with the umbrella sampling
restraining potentials. Other order parameters have been used by other investigators,
for example, the distance between the C𝛼 atoms of G451 and S652 [30]. Our chosen
order parameter was intended to sufficiently capture the principal conformational
transition inferred from LBD crystal structures. We acknowledge, however, that an
order parameter with higher dimensionality would be required to capture motions
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involving additional degrees of freedom.
In our previous studies [28, 31, 32], we have found that umbrella sampling win-
dows spaced 1 Å apart along 𝜉1 and 𝜉2 provide sufficient sampling overlap between
neighboring windows. Windows spanning (𝜉1, 𝜉2) = (8, 6) to (18,17) (in Å) appear to
provide reasonable coverage of conformational space (Fig. 2-4). Initially, for GluA2,
∼200 windows were used [28]. Many of these windows, however, turned out to reside
in regions of high conformational free energy. Subsequently, for GluN1, GluN2A,
and GluN3A, the number of windows was cut to the ∼100 that contribute most to
⟨𝜌(𝜉1, 𝜉2)⟩ [32]. Windows in the "corner" regions, which correspond to either large 𝜉1
and small 𝜉2 or small 𝜉1 and large 𝜉2, are the windows that are generally very high in
conformational free energy and can be safely omitted from the computation.
2.3.4 Setting Up the System
Molecular simulations require complete protein models; that is, any missing non-
hydrogen side chain or backbone atoms in a PDB entry must be built into the model.
For building missing sidechains, we routinely use the program SCWRL [33]. For
building missing backbone atoms, we use the loop-modeling routine of the program
MODELER [34], also available via the ModLoop server (modbase.compbio.ucsf.edu).
The next task is to generate initial protein configurations for each of the umbrella
sampling windows. We use a targeted (biased potential) MD procedure to generate
these LBD configurations. In this procedure, the C𝛼 atoms of lobes 1 and 2 are sep-
arately restrained to their crystal structure configuration using an RMSD restraining
potential while the lobes are pushed apart by performing dynamics in the presence
of biasing potentials applied separately to 𝜉1 and 𝜉2. These simulations are run in
vacuum. The intent of the RMSD restraints is to prevent the lobes from partially
unfolding while 𝜉1 and 𝜉2 are rapidly moved apart. First, 𝜉1 and 𝜉2 are simultane-
ously incremented starting from a closed-conformation crystal structure. Next, 𝜉1
and 𝜉2 are individually incremented starting from configurations generated in the
previous step. System setup concludes with solvating each conformer with explicit
water and 100-150 mM NaCl. Nonzero total charge on the protein (and ligand, if
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present) may be neutralized by using excess Na+ or Cl− ions. We retain the positions
of crystallographically-determined water molecules within the binding cleft.
2.3.5 Small Molecule Parametrization
For iGluR ligands (small organic molecules) that are not amino acids, the molecular
mechanics parameters and charges will need to be determined. This can be accom-
plished a number of ways. One approach is to use the general AMBER force field
(GAFF) [35] together with Antechamber, a toolkit for automatic atom typing [36].
For CHARMM-consistent parameters, the CHARMM general force field (CGenFF)
program can be used for automatic atom typing and assignment of parameters and
charges by analogy [37,38]. Alternatively, a method called general automated atomic
model parameterization (GAAMP) can be used to generate parameters based on
the results of ab initio quantum mechanical (QM) calculations [39]. GAAMP can
also be used to optimize existing parameter sets. Two web portals are available
for automatic parameterization of small compounds using CGenFF: ParamChem
(www.paramchem.org) and MATCH (brooks.chem.lsa.umich.edu). A web portal for
GAAMP is at gaamp.lcrc.anl.gov. Finally, parameterization can be performed man-
ually. Our approach for DNQX [28] included the following steps: (1) charge fit a
geometry-optimized molecule to QM electrostatic potential maps, (2) optimize force
constants by reproducing vibrational frequencies and potential energy distributions
from QM calculations, and (3) optimize dihedral angle parameters by reproducing
dihedral potential energy surfaces from QM calculations.
2.3.6 Equilibriation and Production
Each system must be equilibrated before sampling data are collected. The steps we
routinely take are described below:
- First, the protein and ligand atoms are held fixed while dynamics are carried out
on the solvent.
- Next, dynamics are carried out in the presence of stabilizing restraining potentials
on the protein and ligand. These restraints are gradually reduced over the course
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of the equilibration, which is carried out in the constant atom number, volume, and
temperature (NVT) ensemble.
- Finally, after these restraints have been removed, the simulation is transitioned to
a constant pressure (NPT) ensemble.
In all steps of the equilibration involving non-fixed protein and ligand atoms, the
umbrella restraints on 𝜉1 and 𝜉2 are also applied, as well as weak restraints on the
COM of three regions in the core of lobe 1. The latter restraint, which does not
hinder inter-lobe dynamics, prevents translation and rotation of the protein during
the production phase of the simulations.
The most effective way to implement the restraints described above vary depend-
ing on which MD simulation package is used. For example, in CHARMM, we use the
restraint invoked by the keywords "CONS HARM" for the stabilizing potential. The
"MMFP GEO SPHERE RCM DISTANCE" restraint is used for 𝜉1 and 𝜉2, and the
"CONS HMCM" restraint is used for translation/rotation. The "MMFP" module
allows the instantaneous values of 𝜉1 and 𝜉2 to be written on-the-fly. Details speci-
fying how to use these keywords are included in CHARMM’s "doc" (documentation)
directory.
The simulations enter production phase after equilibration has completed. Here,
the values for 𝜉1 and 𝜉2 in each window 𝑖 are recorded, which contribute to the biased
distribution function ⟨𝜌(𝜉1, 𝜉2)⟩(𝑖). It is critical that all distributions are carefully
monitored to make sure there is sufficient overlap between neighboring windows, which
is a requirement of WHAM [24]. If deficiencies are observed, additional windows
at intermediate positions may be added. Additional windows may also be added
to expand the boundaries of (𝜉1, 𝜉2) if, after computing 𝑊 (𝜉1, 𝜉2), it is determined
that the free energy basins have not been sufficiently mapped. Automated adaptive




Once 𝑊 (𝜉1, 𝜉2) has been computed, the quality of the sampling can be assessed. Two
methods of analysis are block averaging and bootstrapping. In block averaging, as
the name suggests, the sampling data (e.g., (𝜉1, 𝜉2)) are divided into 𝑀 segments, or
"blocks", corresponding to a given simulation time. The PMF is then calculated for
each block, and error bars can be generated to represent the deviation observed in
the 𝑀 PMFs. For a recent example of block averaging applied to umbrella sampling,
see Park et al. [41]. In bootstrapping [42], "resampled" data sets are constructed by
randomly selecting data points from the original sampling data. The resampling takes
place using time intervals estimated to correspond to the time it takes for correlated
fluctuations in (𝜉1, 𝜉2) to decay to zero. Previously, we used time intervals of 300 ps
for GluN LBDs and 200 ps for the GluA2 LBD [32]. Resampling is repeated until
each resampled data set is the same size as the original. The PMF is then calculated
for each resampled set, and error bars can be generated as described above.
Ensuring that convergence in the sampling has been reached, using, for exam-
ple, one or both of the methods described above, is an important step in molecular
simulation studies. It is also a prerequisite for reasonably comparing the computed
free energies with experimental measurements. For the computations described in
this chapter, which are focused on large-scale conformational transitions, experimen-
tal measurements that, at least in principle, can be compared fairly directly include
those that characterize conformational ensembles in solution, such as small-angle
X-ray scattering (SAXS) [28, 43], and nuclear magnetic resonance (NMR) [44] and
fluorescence resonance energy transfer (FRET) spectroscopy [45]. The computed free
energy landscapes provide Boltzmann weights to be applied to the molecular config-
urations extracted from the simulations, which in turn provide a framework, based
on molecular ensembles, for interpreting the measured data.
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Fig. 2-1: A molecular mechanics potential energy function typically includes
terms describing bond stretching (𝑏), bond angle bending (𝜃), bond twisting (𝜑),
improper dihedrals (𝜒), and non-bonded interactions (𝑟).
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Fig. 2-2: Free energy barriers. In unbiased molecular simulations, one or more
large free energy barriers along an order parameter, 𝜉, can impede conformational
sampling (depicted in red).
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Fig. 2-3: Order parameters. Our chosen order parameter, (𝜉1, 𝜉2), used to de-
scribe large-scale conformational transitions in the GluA2 LBD. 𝜉1 and 𝜉2 indicate
the distances between the centers of mass of the atoms that are shown as spheres. In
this figure, (𝜉1, 𝜉2) = ( 12.8 Å, 11.4 Å)
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Fig. 2-4: Umbrella sampling involving the GluN1 glycine-bound LBD. The top
panel shows the umbrella restraining potential equilibrium positions of the 93 windows
that produce the free energy landscape shown in the bottom panel. In the bottom
panel, each contour level corresponds to a difference of 1 kcal/mol, and darker regions
are lower in free energy. See Yao et al. [32] for details.
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Chapter 3 - High conformational variability in the
GluK2 kainate receptor ligand-binding domain
Reproduced in part from a manuscript accepted at:
Structure
by
Tyler J. Wied, Alfred C. Chin, Albert Y. Lau
59
The kainate family of ionotropic glutamate receptors (iGluRs) mediates neuro-
transmission in pre- and post-synaptic neurons. Previously computed conformational
potentials of mean force (PMFs) for iGluR bilobed ligand-binding domains (LBDs)
revealed subtype-dependent conformational differences between AMPA and NMDA
iGluR families. Here we report PMFs for GluK2, a member of the kainate receptor
family, in apo and glutamate-bound states. Both apo and glutamate-bound GluK2
LBDs preferentially access a closed-cleft conformation. Apo GluK2 exhibits a sur-
prisingly high degree of conformational flexibility, accessing both open and closed
states. Comparing across iGluR subtypes, these results are most similar to the
glycine-binding GluN1 and GluN3A subunits of the NMDA receptor family and dif-
fer from glutamate-binding GluA2 and GluN2A subunits. To test the thermody-
namic contribution of cross-lobe interactions on the stability of closed-cleft LBDs,
we computed PMFs for two GluK2 mutants, D462A and D656S. D462A, but not
D656S, significantly weakens the closed-cleft conformation of the glutamate-bound
LBD. Small-angle X-ray scattering (SAXS) experiments were carried out using the
glutamate-bound GluK2 LBD and compared with a theoretical SAXS profile derived
from the PMF. Weighting the theoretical SAXS calculation by the PMF, which rep-
resents a Boltzmann distribution of LBD conformations, improves agreement with
the experimental result compared with a calculation using only the crystal structure
of the LBD, thereby validating our free energy calculations. Principal component
analysis (PCA) sheds light on the different conformational dynamics experienced by
glutamate-bound and apo GluK2 during simulation, and these different modes of
motion could be important for channel gating. Finally, an initial structural charac-
terization of apo GluK2 is presented.
3.1 Background
Ionotropic glutamate receptors (iGluRs) mediate neurotransmission at excitatory
synapses in the mammalian central nervous system [1]. Proper iGluR function is
required for higher-order processes such as learning, memory, and synaptic plastic-
ity, and their central role in cognition makes them attractive pharmaceutical tar-
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gets [2]. The four primary iGluR families are the kainate receptors, 𝛼-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, N-methyl-D-aspartic
acid (NMDA) receptors, and 𝛿 receptors [3, 4]. Kainate receptors are expressed both
pre- and post-synaptically, where they modulate cell depolarization, neurotransmitter
release, and neuronal excitability [5, 6].
Functional iGluRs are tetrameric assemblies in which each protein subunit consists
of an amino-terminal domain (ATD), a clamshell-like ligand-binding domain (LBD),
a transmembrane pore domain (TMD), and a regulatory C-terminal tail (CTD) [7].
Receptor activation is associated with a series of coupled conformational changes
that begin with the binding of an agonist to the LBD, which triggers LBD closure
and concomitant opening of the ion channel pore. iGluRs exhibit a wide array of
gating kinetics [4]. AMPA and kainate receptors generally exhibit rapid activation,
deactivation and desensitization kinetics. NMDA receptors are much slower than
AMPA and kainate receptors, activating on the order of tens to hundreds of millisec-
onds, and deactivating on timescales between tens and thousands of milliseconds,
with weak desensitization. In addition to ion channel activation, glutamate binding
and LBD dynamics mediate iGluR biogenesis. Conformational transitions between
open and closed states of kainate receptors regulate plasma membrane expression and
oligomeric assembly [8].
The conformational free energy landscapes, or potentials of mean force (PMFs),
governing LBD closure for apo and natural agonist-bound proteins have been re-
ported for AMPA and NMDA receptors but not for kainate receptors [9–12], although
PMFs have been reported for a kainate receptor LBD bound to photoswitchable lig-
ands [13, 14]. AMPA and NMDA receptor LBDs are characterized by a spectrum of
qualitatively different PMFs. For instance, closed LBD conformations are energeti-
cally unfavorable for apo GluA2, preferring instead to sample open conformations,
whereas apo GluN3A and GluN1 readily access both open and closed conformations.
Glutamate-bound NMDA and AMPA receptors possess global free energy minima in
a closed conformation, with energetically unfavorable open states, but the steepness
of the PMFs between open and closed conformations varies among subtypes. In this
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study, we sought to determine whether computed PMFs for the LBD of a prototyp-
ical kainate receptor, GluK2, more closely resemble AMPA or NMDA receptors, or
whether they are unique. This knowledge would advance our understanding of the
structural thermodynamics underpinning iGluR function.
Here we report PMFs for apo and glutamate-bound GluK2 LBDs, computed us-
ing umbrella sampling molecular dynamics (MD) simulations. There are notable
differences observed between the GluK2 PMFs and the PMFs of glutamate-binding
NMDA and AMPA receptor subunits. Apo GluK2 is stable in both open and closed
cleft conformations, unlike apo GluA2 and GluN2A, which preferentially access open
conformations. One plausible factor contributing to the observed differences are cross-
lobe interactions across the LBD cleft. Kainate receptor LBDs have several cross-lobe
interactions that are not present in AMPA receptors, and these interactions have been
reported to regulate the affinity for glutamate [15]. Additionally, GluK2 with cleft
residues mutated to analogous GluA2 residues behave similarly to GluA2 in electro-
physiology experiments, and vice versa with GluA2 residues mutated to analogous
GluK2 residues [15]. To test the thermodynamic contribution of these cross-lobe
interactions, we mutated two residues that participate in two sites of cross-lobe in-
teraction, D656S and D462A, and computed the PMFs in the glutamate-bound and
apo states. Our results predict a reduction in the stability of the D462A LBD in
closed conformations, consistent with the functional assays. We compare experimen-
tal small-angle X-ray scattering (SAXS) results using the GluK2 LBD with a the-
oretical SAXS profile generated from a PMF-weighted ensemble of LBD-glutamate
complex conformers. Next, we perform principal component analysis and show that
apo and glutamate-bound GluK2 sample phase space differently. Whereas apo GluK2
experiences most of its motion hinge bending, glutamate-bound GluK2 experiences a
variety of conformational motions. PCA might identify modes of motion important
for channel gating beyond hinge bending. For instance, a twisting motion in GluA2
was previously shown to contribute significantly to GluA2 activation [16]. Finally,
we present structural characterization of apo GluK2. We validate the absence of
glutamate in solution by performing a protease protection assay as well as circular
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dichroism which shows slight changes to secondary structure. We then present initial
attempts to characterize apo GluK2 by SAXS and X-ray crystallography.
3.2 Results
3.2.1 Conformational dynamics of the GluK2 LBD
To probe the conformational dynamics of the GluK2 LBD, we computed conforma-
tional PMFs for glutamate-bound and apo LBDs. The PMFs were computed using
an umbrella sampling approach along a two-dimensional (2D) order parameter, (𝜉1,
𝜉2), that reports the extent of openness of the LBD clamshell (Fig. 3-1). 𝜉1 and 𝜉2
each corresponds to a distance between the top lobe (Lobe 1) and the bottom lobe
(Lobe 2) of the LBD. This approach has been previously employed to study large-
scale conformational transitions in iGluR LBDs [9–12,17]. The glutamate-bound and
apo LBDs share a global free energy minimum in the closed state at (𝜉1, 𝜉2) = (10.1,
7.6 Å) and (10.5, 6.1 Å), respectively (Fig. 3-2). However, whereas the glutamate-
bound LBD possesses only one free energy minimum, the apo LBD exhibits a broad
free energy basin at more open conformations extending from (𝜉1, 𝜉2) = (12, 10 Å)
through (19, 20 Å). As expected, the LBD is freer to explore open conformations in
the absence of a bound glutamate ligand (quantified below). This freedom, however,
is surprisingly large, as the open-state basin remains below 2 kcal/mol, for the most
part.
To test the contribution of cross-lobe interactions to the thermodynamic stability
of the closed-cleft conformation, we disrupted these interactions by separately generat-
ing the cleft residue mutations D656S and D462A, where the amino acid substitutions
are the analogous residues in GluA2. The PMF of the glutamate-bound D656S LBD
resembles the PMF of its wild-type (WT) counterpart and features a global free en-
ergy minimum at (𝜉1, 𝜉2) = (10.0, 7.2 Å), with increasing free energies at more open
conformations (Fig. 3-3A). The PMF of the apo D656S LBD also looks broadly sim-
ilar to the PMF of the WT apo LBD, with a global minimum at (𝜉1, 𝜉2) = (10.0, 6.5
Å) (Fig. 3-3B). In the D656S PMFs, however, the free energy well in the immediate
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vicinity of the crystallographic closed state (see Fig. 3-2A) is narrower compared
with the WT PMFs. This suggests the D656S mutation may slightly destabilize the
crystallographic closed conformations. Overall, however, the thermodynamic effect
of D656S appears to be small. In contrast, the D462A mutant significantly destabi-
lizes closed-cleft conformations in the glutamate-bound LBD (Fig. 3-3C), with the
free energy of open state configurations reaching only 1–2 kcal/mol compared with
4–5 kcal/mol for WT and D656S (Fig. 3-2A and Fig. 3-3A,C). Nonetheless, both
apo and glutamate-bound D462A LBDs share a global free energy minimum near the
crystallographic closed state [apo: (𝜉1, 𝜉2) = (10.3, 6.1 Å), glutamate bound: (𝜉1,
𝜉2) = (9.9, 6.0 Å)]. Results for apo D462A broadly resemble WT GluK2, suggesting
minimal effect of the mutation.
On the other hand, the open states of the glutamate-bound D462A LBD are
substantially more favorable than either the glutamate-bound WT or D656S LBDs
(Fig. 3-3C). This suggests D462 plays an important role in stabilizing closed-cleft
conformations. The PMF of the apo D462A LBD is similar to that of the apo WT
LBD (Fig. 3-3D). Presumably, since the apo LBD is already highly flexible, the
D462A mutation produces little effect in the apo LBD. Error analysis for all PMFs
are provided in Fig. 3-4.
How do the WT GluK2 LBD PMFs compare with the PMFs previously computed
for AMPA and NMDA receptor LBDs in [9, 11]? Superposition of 1D projections of
the 2D PMFs into an order parameter called 𝜉12 (see section 3.4) is a convenient way
to compare PMFs (Fig. 3-5). The iGluR subtypes are structurally similar but not
identical, which permits the comparison in 𝜉12, albeit imperfectly. The PMF of the
glutamate-bound GluK2 LBD resembles the PMFs for agonist-bound GluA2, GluN1,
GluN2A, and GluN3A LBDs in that the global free energy minimum resides in the
closed state, and the free energy increases in more open conformations (Fig. 3-5A).
The slopes of the PMFs vary by iGluR subtype, with glutamate-bound GluA2 be-
ing the steepest and GluK2 being the shallowest. In other words, GluK2 exhibits
the lowest free energy barriers to accessing open conformations. The PMF of the
glycine-bound GluN1 closely resembles that of GluA2, whereas the slopes of both
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the glutamate-bound GluN2A and the glycine-bound GluN3A are in between that
of GluA2 and GluK2. The bi-stable PMF of the apo GluK2 LBD is most similar to
the glycine-binding NMDA receptor subtypes GluN1 and GluN3A (Fig. 3-5B). The
PMFs of apo GluA2 and GluN2A are different in that they contain one broad free
energy basin in open conformations and are relatively unstable in closed conforma-
tions.
3.2.2 Free energy difference between open and closed GluK2
LBDs
How can one define whether a given GluK2 LBD conformation is open or closed?
One approach to differentiate these states is to define closed states as those that do
not permit entry or exit of a glutamate ligand into or out of its binding pocket. The
program CAVER [18] was used to search for possible passageways for glutamate be-
tween the protein surface and the binding cavity, given glutamate’s estimated van der
Waals radius of 3.22 Å [19]. Multiple LBD conformers generated by the simulations
were evaluated, and a single access tunnel was identified. Y457 in Lobe 1 and V654
in Lobe 2 were identified as "bottleneck" residues that form the tightest constriction
point along the tunnel (Fig. 3-6A). In a closed state, these bottleneck residues pre-
vent the passage of glutamate into or out of the LBD. These residues are in nearly
analogous locations as bottleneck residues previously identified in a ctenophore iGluR
LBD [17]. At least 12 Å between the Y457 and V654 𝐶𝛾 atoms is estimated to be
required for glutamate to access its binding site. Therefore, conformations, i.e., (𝜉1,
𝜉2), with bottleneck distances greater than 12 Å are classified as open, and all others
are classified as closed. Plots of average bottleneck distance vs. (𝜉1, 𝜉2) for WT,
D656S, and D462A LBDs are shown in Fig. 3-6B-G. The values in each plot were
calculated using ∼120,000 snapshots extracted from the simulations.
In an equilibrium ensemble of LBD conformations, what fraction is open vs.
closed? The relative probability of the LBD occupying each state is determined
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where 𝑊 (𝜉1, 𝜉2) is the PMF, and the region of integration corresponds to either
(𝜉1, 𝜉2) in which the bottleneck distance ≥12 Å (open) or <12 Å (closed); 𝑘𝐵 is Boltz-
mann’s constant, and 𝑇 is temperature. The conformational free energy difference
between open and closed states is then given by,











Values of Δ𝐺conf and ΔΔ𝐺conf are provided in Table 1. Bound glutamate stabilizes
the closed cleft WT GluK2 LBD by 2.8 kcal/mol relative to its apo state, 2.6 kcal/mol
for D656S, and 0.4 kcal/mol for D462A. The D462A mutation almost eliminates the
difference between the glutamate-bound and apo states, suggesting that D462 plays
an important role in stabilizing the closed cleft when glutamate is bound. In contrast,
the D656S mutation has only a marginal effect on the stability of glutamate-bound
and apo LBDs.
3.2.3 Small-angle X-ray scattering
How accurate are our computed conformational PMFs? To address this question, we
compared theoretical small-angle X-ray scattering (SAXS) profiles generated using
our PMFs with experimental SAXS data. A similar comparison has previously been
carried out involving the GluA2 LBD in complex with several ligands [9]. Theoretical
SAXS profiles were calculated, using CRYSOL [20], for 1369 simulated configura-
tional snapshots spanning (𝜉1, 𝜉2). A single Boltzmann-weighted average profile was
calculated from each of the profiles, where the weights are given by the computed
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PMF (see section 3.4). Additionally, the theoretical SAXS curve was calculated for
the crystal structure of the glutamate-bound GluK2 LBD (PDB: 1S50) [21]. These
theoretical profiles can be directly compared with experimental SAXS data, which
represent an ensemble protein conformational distribution in solution [22]. Fig. 3-7
shows a comparison of the theoretical SAXS profile, calculated using the glutamate-
bound LBD PMF, with experimental SAXS data, collected using the GluK2 LBD in
the presence of 10 mM glutamate, a concentration at which ∼100% of LBDs should
be bound to glutamate [21].
The theoretical and experimental SAXS curves were scaled to 𝐼0 and compared
by computing the chi-squared statistic, 𝜒2. There is good agreement between the
experimental and theoretical SAXS curves from simulation, 𝜒2 = 3.0, which is a
better overall fit to the experimental data than the theoretical SAXS curve from the
crystal structure alone, 𝜒2 = 17.8. There is also good agreement between the radii of
gyration, 𝑅𝑔, with experimental 𝑅𝑔 = 19.9 Å and theoretical 𝑅𝑔 = 19.6 Å, which are
both larger than the crystal structure 𝑅𝑔 = 19.1 Å. These results suggest that our
simulations accurately capture the populations of relevant LBD conformations that
are not reflected in the crystal structure alone.
3.2.4 Structural characterization of apo GluK2
Apo GluK2 was purified by exhaustive dialysis (∼1020-fold serial dilution) into solu-
tions not containing l-glutamate. Apo LBDs can be distinguished from glutamate-
bound GluK2 via protease protection assay [23] and circular dichroism (Fig. 3-8).
Proteolysis protection assays were carried out for GluK2 in the presence of the trypsin
protease. Glutamate-bound GluK2 is resistant to trypsin digestion after 120 minutes
(Fig. 3-8A, top and bottom). Apo GluK2 LBD, in contrast, is vulnerable to trypsin
digestion, and is nearly completely digested after 120 minutes (Fig. 3-8A, middle).
Additionally, small differences are observed between apo and glutamate-bound GluK2
in their circular dichroism (CD) spectra, which is used to determine protein secondary
structure character. Relative to apo GluK2, glutamate-bound GluK2 has more 𝛽-I
character. This suggests the LBD loses some of its beta sheet character in its apo
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form, perhaps in the hinge, which undergoes the most structural change between open
and closed conformations. We attempted to carry out SAXS experiments using the
apo GluK2 LBD, but the protein persistently aggregated during our measurements.
There is no crystal structure of an apo GluK2 LBD. Preliminary attempts to grow
apo GluK2 crystals generated promising hits, but we were ultimately unsuccessful in
producing crystals viable for structure determination. Promising crystal hits are
shown in Fig. 3-9. A complete summary of crystallization attempts are detailed in
section 3.4. Generally, the vast majority of drops containing 7.5 mg/mL protein
formed precipitates. Notably, conditions that produce crystals for glutamate-bound
GluK2 [21] do not produce crystals for apo GluK2.
3.2.5 Principal component analysis
To assess large-scale conformational motions in our simulations, principal component
analysis (PCA) was performed on apo and glutamate-bound GluK2 LBDs Fig. 3-10.
For both apo and glutamate-bound GluK2, PC1 is a hinge bending, which corresponds
to the canonical opening/closing of the LBD. PC2 for the apo LBD is a ’sweeping’
motion, whereas for glutamate-bound LBD it is a ’rocking’ motion. PC3 for the apo
form is the ’rocking’ motion and for the glutamate-bound form PC3 corresponds to
the ’sweeping’ motion. Notably, 87% of the variance is contained within PC1 alone
for apo GluK2, and 93.2% of the variance is contained within PC1-3. The glutamate-
bound LBD contains 28.1% of its variance within PC1, and only 56% of its variance
within PC1-3. This suggests that motions of the apo form are dominated by the hinge-
bending motion, whereas this motion is attenuated heavily in the glutamate-bound
LBD. It is possible that the non-hinge bending motions observed here, such as the
"sweeping" or "rocking" motions observed in PC1-2, play a role in the conformational
dynamics of full-length receptor assemblies.
3.3 Discussion
To assess the conformational thermodynamics of GluK2 LBDs, we computed PMFs
for GluK2 LBDs in apo and holo states. The glutamate-bound GluK2 LBD favors
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a closed-cleft conformation, whereas apo GluK2 is highly flexible and can access a
broad region of conformational space spanning closed and open conformations. The
PMF of glutamate-bound GluK2 resembles the PMFs of other agonist-bound iGluR
LBDs, but with a shallower free energy profile in open conformations. Apo GluK2 is
unique in that it can access both closed and open conformations – other apo iGluRs
that bind glutamate do not access closed conformations with a high probability. To
quantify the free energy difference between open and closed LBD states, we classi-
fied conformational snapshots into "open" and "closed" states based on a bottleneck
analysis of ligand-binding tunnels. This approach allows us to calculate the effect
glutamate has on the relative stability of open and closed LBD conformations. It
should be noted that the free energy calculations presented here constitute only a
partial contribution to the total free energy of glutamate binding, as ligand docking
is not taken into account. For a complete treatment of ligand-binding free energies
to an iGluR LBD, see [10].
Why can apo GluK2 easily access a closed cleft conformation, but apo GluA2
cannot? One possibility is the presence of cross-lobe interactions not present in the
GluA2 LBD. To test the thermodynamic effect of disrupting inter-cleft interactions,
we computed PMFs for two mutants, D656S and D462A, in which the substituted
amino acids are the analogous residues in GluA2. We found that D462A, but not
D656S, significantly destabilizes the closed-cleft LBD, effectively stabilizing the open
LBD. Notably, it was the PMF of the glutamate-bound, and not apo, D462A LBD
that was most significantly affected. Apo D462A GluK2 still visits the closed state
with a high relative probability.
Another explanation for the LBD’s thermodynamic behavior is bulk electrostatic
attraction or repulsion between the top and bottom lobes, as has been discussed
previously for GluA2 [24]. The GluA2 LBD has a total net charge of +5, where the
top lobe of has a +4 charge, and the bottom lobe has a +1 charge, hence the two
lobes should experience net repulsion. The GluK2 LBD upper lobe has a net charge
of -2, and the bottom lobe has a net charge of 0, suggesting GluK2 experiences
less cross-lobe repulsion than GluA2. More specifically, repulsion between protein
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surfaces of the upper and lower lobes might predict the preference for apo LBDs to
visit closed cleft conformations. Fig. 3-11 and Fig. 3-12 show electrostatic surfaces
for various iGluR LBDs both from the "front" of the LBD and the surfaces of the
upper and lowers that face the binding cleft. From these views, deep blue pockets can
be observed, corresponding to the glutamate/glycine binding pocket. However, other
than that, the surfaces are heterogeneous, and it is difficult to draw general conclusions
from these surfaces. A Poisson-Boltzmann calculation or perhaps the CHARMM
Block module, which allows users to tune what forces groups of atoms "feel", would
reveal the Coloumbic contribution to the PMFs presented here. We attempted to
use the CHARMM Block module to address this question, and encountered strange
behavior. Specifically, with our configuration of Block, it causes an acceleration of
the protein in the Z dimension. This does not appear to be dependent on choice of
integrator or ensemble (NPT vs NVT).
To compare simulation results with experiment, we performed SAXS on the GluK2
LBD and computed theoretical SAXS curves from our simulated ensemble. Overall,
the agreement between the simulation and experiment are an improvement over a
comparison with the crystal structure alone, suggesting the glutamate-bound GluK2
LBD accesses an array of conformational states not represented by the crystal struc-
ture. Previous comparisons of LBD PMFs with SAXS [9] and single-molecule FRET
(smFRET) [25] studies have also shown good agreement between experimental and
computational results.
Here the intrinsic conformational thermodynamics of a monomeric GluK2 LBD
is studied. Future studies will address the conformational dynamics of LBD dimer
assemblies as well as intact, tetrameric receptors.
3.4 Methods
3.4.1 Molecular dynamics simulations
Molecular dynamics simulations were carried out in CHARMM [26] and NAMD [27]
using the TIP3P water model [28]. The GluK2 LBD was chosen as a representative
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kainate receptor LBD (PDB: 1S50, chain A) [21]. The N-terminal glycine residue not
modelled in the crystal structure was built using MODELLER [29]. Crystallographic
waters buried within the LBD were included in the simulations, whereas waters out-
side the LBD were removed. A 90 × 70 × 60 Å3 orthorhombic water box with ∼150
mM NaCl was used for all simulations; the number of ions was adjusted to set the net
charge of the system to zero (apo: Na+ = 30, Cl− = 28; glutamate-bound: Na+ = 30,
Cl− = 27). In simulations of glutamate-bound LBD, the ligand was prevented from
dissociating from the binding pocket by using a half-harmonic restraint to keep the
𝛼-carboxyl oxygens of the ligand within 2.8 Å of the guanidine group of R492. Ini-
tial conformations for umbrella sampling were generated using biasing potentials [9].
Equilibration took place in the NVT ensemble using applied restraints on backbone
and sidechain atoms, which were slowly released during equilibration. Production
runs took place in the NPT ensemble at 1 atm and 300 K [30]. Electrostatic interac-
tions were computed using the particle mesh Ewald (PME) algorithm [31]. Umbrella
sampling was performed using a 2D order parameter, (𝜉1, 𝜉2). The first dimension,
𝜉1, is defined as the distance between the center-of-mass of all non-hydrogen atoms
in residues 90–92 in the top lobe and the center-of-mass of non-hydrogen atoms in
residues 142–143 in the bottom lobe. The second dimension, 𝜉2, is defined as the
distance between the center-of-mass of non-hydrogen atoms in residues 12–14 in the
top lobe and the center-of-mass of non-hydrogen atoms in residues 174–175 in the
bottom lobe. A force constant of 2 kcal/mol/Å2 was used for 𝜉1 and 𝜉2. This order
parameter spans the relevant regions of conformational space surrounding the closed-
and open-cleft conformations observed in crystal structures.
3.4.2 Free energy calculations
126 windows were used for umbrella sampling, and each window was sampled for 1.8
ns, for a total of 226.8 ns. Umbrella sampling distribution functions were unbiased
and recombined using the weighted histogram analysis method (WHAM) [32,33].
1D projections of the 2D PMFs were generated by computing the PMF along a
hybrid order parameter that is the average of 𝜉1 and 𝜉2, which we call 𝜉12. This is
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done by mapping each 𝜉1 and 𝜉2 pair to a bin in 𝜉12, with a bin width of 0.1 Å, and
then summing the values from the 2D unbiased distribution in each bin to create a
1D unbiased distribution. The 1D PMF, W(𝜉12), is given by,






where is the 1D unbiased distribution function, and is the partition function.
Uncertainty in the simulation results was assessed by block averaging [34]. Briefly,
the simulation trajectory for each umbrella sampling window was split into ten equally
sized "blocks", and WHAM was performed on each of the blocks to generate ten block
PMFs. The standard deviation of the block PMFs was then computed.
3.4.3 Expression and purification of the GluK2 LBD
The GluK2 LBD construct was provided by Mark Mayer (NIH) on a pET-22b plas-
mid (Novagen), with the same sequence as previously described [21]. The GluK2
LBD expresses as a soluble, monodisperse protein in BL21(DE3) E. coli (Novagen).
Expression was carried out in cultures of Terrific Broth grown to OD600 = 0.7 in the
presence of 100 𝜇 g/mL Ampicillin and induced with 400 𝜇M IPTG overnight at 4∘C.
Purification was performed on a Ni2+ NTA column (Roche), followed by thrombin
cleavage and size exclusion chromatography. For SAXS and the proteolysis protection
assay, purified protein was dialyzed into a solution containing 20 mM NaCl, 2 mM
Tris, pH 8, 10 mM l-glutamate, 1% glycerol, and 1 mM TCEP.
3.4.4 Small-angle X-ray scattering
SAXS experiments were performed using an in-house Rigaku BioSAXS-2000 system.
Different concentrations of GluK2 LBD (0.5, 1, 2, 5 mg/mL) were suspended in a
buffer containing 20 mM NaCl, 2 mM Tris, pH 8, 10 mM l-glutamate, 1% glycerol and
1 mM TCEP. Samples were loaded into the capillary by an automatic sample changer.
Buffer subtraction and data merging were performed using SAXSLab (Rigaku).
Theoretical SAXS curves were generated using CRYSOL [35],with the solvent den-
sity value set to 0.36 electrons/Å3, which lies within an acceptable range, as previously
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described [20]. A total of 1369 randomly-selected snapshot conformations were used
to generate an ensemble of SAXS curves. A Boltzmann weight determined by the
corresponding PMF value for each conformation was applied to the output intensity
values. These weighted SAXS curves were then combined into a final Boltzmann-









where I𝑠𝑜𝑙(𝑞) is the intensity curve, W𝑗(𝜉1, 𝜉1) is the PMF, 𝑘𝐵 is Boltzmann’s
constant, and 𝑇 is temperature. The Guinier approximation was used in the range
where 𝑞𝑅𝑔 < 1.3 to calculate the radius of gyration, R𝑔, and the forward scattering,







where the slope and y-intercept of a plot of [ln(I(q)) vs. q2] give the R𝑔 and I0,
respectively. The 𝜒2 function was used to assess the agreement between the theoretical











where N is the number of data points in the scattering profile, 𝐼exp(𝑞𝑚) and
𝐼calc(𝑞𝑚) are the experimental and calculated scattering profiles, respectively, and
𝜎(𝑠𝑖) is the experimental standard deviation. Interpolation of data was performed
using a cubic spline.
3.4.5 Structural characterization of apo GluK2
Apo GluK2 is obtained by exhaustive dialysis (∼1020-fold serial dilution) into a buffer
containing 20 mM NaCl, 2 mM Tris, pH 8, and 1% glycerol. The dialyzed protein
solution was run over a size-exclusion chromatography column to remove aggregated
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protein. Limited proteolysis protection assays were performed with 1 mg/mL purified
apo and glutamate-bound GluK2 with the buffer composition described above, as
well as purified apo GluK2 with 10 mM l-glutamate re-added just prior to the assay.
Trypsin was added (1/20 wt/wt ratio) to room temperature protein samples, and
reaction aliquots were collected at 30, 60, and 120 minutes for SDS-PAGE. Control
reactions were performed in the absence of trypsin as well as excess trypsin. Circular
dichroism (Aviv Model 400 CD spectrometer) was carried out between 190 and 300
nm in buffers containing 20 mM NaCl, 2 mM Tris, pH 8, 2% glycerol, 0.25 mM TCEP,
and 10 mM l-glutamate for glutamate-bound GluK2.
Crystal screens for apo GluK2 LBD were carried out with the JCSG Core Suite 1
at various protein concentrations (5 and 7.5 mg/mL) and temperatures (4 ∘C and 20
∘C). Apo GluK2 was suspended in a buffer containing 20 mM NaCl, 2 mM Tris, pH
8, and 1 mM TCEP. Screening was carried out with the hanging drop method with
a mosquito LCP, which combined 300 nL of protein sample with 300 nL of reservoir
solution.
3.4.6 Principal component analysis
Principal component analysis (PCA) was carried out with the Bio3D package for R
( [36]) as previously described in [11]. In brief, a subset ensemble was generated from
the C𝛼 carbons of umbrella sampling conformations within 2 kcal/mol of the global
PMF free energy minima. This subset ensemble was used to generated the covari-
ance matrix from which the eigenvectors and eigenvalues of PCA are computed. We
applied an approximate Boltzmann-weight to the selected conformations: conforma-
tions between 0-1 kcal/mol were duplicated five times relative to the conformations
between 1-2 kcal/mol.
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Fig. 3-1: GluK2 ligand-binding domain structure. (A) A 2D order parameter,
(𝜉1, 𝜉2), describes the conformational state of the LBD in our simulations. 𝜉1 and 𝜉2
each indicate a distance, represented by dashed lines, between the residues shown in
spheres. (B) Residues that participate in interactions between the top and bottom
lobes are depicted. Residues chosen for mutational analysis, D656 and D462, are
labeled.
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Fig. 3-2: Potential of mean force (PMF) calculations for WT GluK2 LBDs.
(A) Glutamate-bound. (B) Apo. 2D PMFs are on the left, and 1D PMFs, which are
projections of the 2D PMFs according to 𝜉12 = (𝜉1 + 𝜉2)/2, are on the right. The
2D PMFs are contoured by 1 kcal/mol increments. 𝜉12 for the 1D PMFs are adjusted
so the 𝜉12 value is set to 0 Å where the glutamate-bound LBD has its global free
energy minimum. Standard deviation is shown in green and is calculated using block
averaging.
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Fig. 3-3: PMFs for mutant GluK2 LBDs. (A) D656S-glutamate, (B) apo
D656S, (C) D462A-glutamate, and (D) apo D462A. 2D plots are on the left, and 1D





Fig. 3-4: GluK2 LBD PMF standard deviations. (A) WT-glutamate, (B)
apo WT, (C) D656S-glutamate, (D) apo D656S, (E) D462A-glutamate, and (F) apo
D462A. Contour lines correspond to the PMF, and colors correspond to the standard
deviation, calculated using block averaging.
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Fig. 3-5: Comparison of 1D PMFs for AMPA, NMDA, and kainate re-
ceptors. (A) Agonist-bound PMFs for GluK2-glutamate (black), GluA2-glutamate
(orange), GluN1-glycine (turquoise), GluN2A-glutamate (red), and GluN3A-glycine
(gold). (B) Apo PMFs for GluK2 (black), GluA2 (orange), GluN1 (turquoise),
GluN2A (red) and GluN3A (gold). The PMFs of the various LBDs are aligned such
that the order parameter, 𝜉12, is set to a value of 0 Å where the agonist-bound LBD
has its global free energy minimum.
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Fig. 3-6: Bottleneck analysis. (A) Residues defining the bottleneck to the gluta-
mate binding site, Y457 and V654. (B-G) The average bottleneck distance at each
(𝜉1, 𝜉2) is overlaid with the corresponding PMF contours. The color corresponds to
the average bottleneck distance. An average bottleneck distance of greater than 12
Å is considered an open conformation. The dashed boxes in the upper right corners





Fig. 3-7: Comparison of experimental and theoretical small angle X-ray
scattering (SAXS) of GluK2 bound to glutamate. (A) SAXS log intensity
plot with an overlay of experimental results (green), theoretical results from MD
simulation (black, left), and theoretical results from the crystal structure alone (blue,
right). The inset boxes in the upper right corners are zoom-ins of the intensity plot
from roughly 0.05 < q < 0.15 Å−1. (B) Guinier plot for experimental results (𝑅𝑔 =
19.9 Å). (C) Guinier plot for theoretical results from MD simulation (𝑅𝑔 = 19.6 Å).
(D) Guinier plot for theoretical results from the crystal structure alone (𝑅𝑔 = 19.1
Å). (E) Kratky plot with its characteristic shape indicating a folded protein.
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Fig. 3-8: Validation of apo GluK2 and SAXS attempts. (A) Proteolysis
protection assay of GluK2 LBD in the presence of trypsin. Glutamate-bound (top
and bottom) GluK2 is resistant to trypsin after 120 minutes. Apo GluK2 (center) is
almost completely degraded after 120 minutes. (B) Circular dichroism suggests subtle
secondary structure differences between apo and glutamate-bound GluK2. Glu-bound
GluK2 appears to have more 𝛽-I character than apo GluK2. (C) Apo GluK2 SAXS
results. These results are strongly indicative of aggregation, even at low (0.5 mg/mL)
concentrations.
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Fig. 3-9: Preliminary crystal screen for apo GluK2 LBD. Shown in A-E are
the most promising hits from JCSG Core Suite 1 with 5-7.5 mg/mL protein at either
4 ∘C or 20 ∘C. GluK2 LBD. Spherulites are seen in 𝐴, phase separation in 𝐵 and 𝐶,
microcrystals/precipitant in 𝐷, and a single collection of crystal shards in 𝐸.
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Fig. 3-10: Principal component analysis of GluK2 LBDs. Top, visualization
of PCs 1-3 for apo and glu-bound GluK2. The red arrow represents an axis of rotation
for the LBD lower lobe. PC1 is a hinge bending motion for both apo and glu-bound.
PC2 for the apo LBD is a ’sweeping’ motion, whereas for glutamate-bound LBD
it is a ’rocking’ motion. PC3 for the apo form is the ’rocking’ motion and for the
glutamate-bound form PC3 corresponds to the ’sweeping’ motion. Bottom, cumula-
tive proportion of variance contained within PCs 1-20. Notably, 87% of variance is
contained with PC1 for apo GluK2, but only 28.1% for glu-bound GluK2.
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Fig. 3-11: Electrostatic potential surface of GluK2 and GluA2. Electro-
static potential surface of GluK2 and GluA2. Separate views of upper and
lower LBD lobes: from the front (left and toward the binding cleft (right). Top,
GluK2. Bottom, GluA2. In both GluA2 and GluK2 the glutamate-binding pocket
can be seen in the areas of deep blue coloring. Qualitatively, GluA2 has more blue





Fig. 3-12: Electrostatic potential surface of GluN1, GluN2A, and GluN3A.
Separate views of upper and lower LBD lobes: from the front (left) and toward the
binding cleft (right). Both GluN1 (top, left) and GluN2A (top, left) have strong pos-
itive patches within the binding cleft, whereas GluN3A (bottom) has strong negative
patches spread throughout the entire protein surface, with only a small positive patch
at the glutamate binding site. These results are also reflected in the total charges of















Table 3.1: Values of Δ𝐺conf and ΔΔ𝐺conf of GluK2 LBDs
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Metabotropic glutamate receptors (mGluRs) are dimeric class C GPCRs that
mediate cellular responses to the neurotransmitter glutamate in the central nervous
system. Crystal structures and single-molecule FRET results suggest that closure of
the ligand-binding domains (LBDs) as well as reorientation of the dimer interface are
necessary conformational transitions for receptor activation. The energetic factors
that drive these coupled processes, however, are poorly understood. Here, we report
free energy landscapes, or potentials of mean force (PMFs), for monomer mGluR3
LBDs in apo and glutamate-bound states as well as glutamate-bound dimer mGluR3
in the active and inactive conformations. PMFs of LBD monomers suggest the glu-
bound LBD are bistable: the closed and open-cleft conformations are accessible for
both glutamate-bound and apo LBDs, but with the apo closed-cleft conformation
destabilized relative to the glutamate-bound. PMFs for the glu-bound dimers indi-
cate a strong preference for the closed state. The energetics corresponding to the
reorientation of the dimer interface are also examined.
4.1 Background
Class C GPCRs are characterized by obligate dimerization and large extracellular
ligand-binding domains (LBDs). This class consists of the GABAB receptors, the
taste receptors for umami and sweet, metabotropic glutamate (mGluR), and calcium
sensing receptors receptors [1]. The mGluRs are widely expressed in the mammalian
central nervous system where they tune synaptic strength by modulating NMDA
receptor activity [2]. Proper mGluR function is required for several higher-order
cognitive processes, such as learning, memory, and synaptic plasticity. They also have
been implicated neurological disorders like schizophrenia and autism [3,4]. The eight
mGluRs are clustered into three phylogenetic groups: Group I (mGluR1, mGluR5),
Group II (mGluR2-3), and Group III (mGluR4, mGluR6-8) [5].
Each mGluR subunit encodes an N-terminal clamshell ligand-binding domain
(LBD) [6], a cysteine-rich domain (CRD), 7-pass transmembrane domain (TMD),
and an intracellular C-terminal domain that serves as a scaffold for binding part-
ners [7]. Closure of the LBD clamshell upon agonist binding is associated with a
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reorientation of the dimer interface which facilitates receptor activation [8]. smFRET
studies reveal that isolated LBD dimers preserve the relevant conformational transi-
tions between active and inactive state [9,10]. Notably, isolated LBD dimers rapidly
oscillate between the active and inactive states on a sub-millisecond timescale, where
agonist increases the probability that the receptor visits the active state [11]. There
is also a transient conformational intermediate between active and inactive poses [10].
Revealing the energetics and molecular mechanisms underlying these dynamics are
essential for a full description of receptor activation.
Here, we present the potential of mean force (PMF) for mGluR3 LBDs. The
LBD PMFs are computed using an umbrella sampling ( [12]) scheme along two order
parameters that describe the openness of the clamshell LBD. We do this for both
glutamate-bound and apo mGluR3 monomers. Next, we compute PMFs for LBDs in
both the active and inactive dimer poses. We find a unique stabilization of the closed
state for LBDs in the presence of their dimer partners, and find altered dynamics in
a lower lobe helix that may explain these observations. Finally, we present a PMF
computed along a pathway corresponding to the dimer interface transition, which we
describe with a dihedral angle Θ.
4.2 Results
4.2.1 Monomer mGluR3 PMFs
To examine the mechanics of mGluR3 LBD cleft motions, we compute the potential of
mean force (PMFs) using umbrella sampling ( [12]) along two order parameters that
capture opening and closing of the LBD. The order parameters, 𝜉1 and 𝜉2, capture
motion along each side of the LBD cleft Fig. 4-1. A similar approach to compute
PMFs has been used in ionotropic glutamate receptors (iGluRs) LBDs ( [13–15]),
but has not been applied to clamshell-like LBDs in non-iGluR systems. PMFs were
computed for monomeric glutamate-bound and apo mGluR3 (Fig. 4-2). Glutamate-
bound mGluR3 is bistable, with free energy minima in the closed state at ((𝜉1, 𝜉2) =
(13.9, 16.3 Å); 𝑊 (𝜉1, 𝜉2) = 0.174 kcal/mol) and in the open state at ((𝜉1, 𝜉2) = (28.2,
100
28.3 Å); 𝑊 (𝜉1, 𝜉2) = 0.0 kcal/mol). The closed-state local minimum is narrower than
than the broad open state basin. There is a ∼3 kcal/mol free energy barrier near
(𝜉1, 𝜉2 = 12.5, 19 Å) separating open and closed conformations. Apo mGluR3 has a
global free energy minimum at (𝜉1, 𝜉2 = 20.8, 22.1 Å), which is located in a similar
position to crystal structures of open mGluR3 LBDs bound to antagonists (see PDB:
3SM9). Error analysis for the monomer mGluR3 LBDs is shown in Fig. 4-3.
It would be computationally convenient in future mGluR simulations that examine
additional degrees of freedom to reduce the description of the LBD state from 2D to
1D. To test whether a simulation in 1D accurately captures the results observed in
2D, we ran independent simulations of mGluR3 LBDs along a single order parameter,
𝜉12, where 𝜉12 = (𝜉1 + 𝜉2)/2. Qualitatively, the 1D PMFs agree with the 2D results:
Glutamate-bound mGluR has a free energy minimum at 𝜉12 = 15.2 Å near the closed
state, and another local minimum more open conformations near 𝜉12 = 19-21 Å with
a ∼4 kcal/mol free energy barrier between the two minima (Fig. 4-4). The apo state
has a global free energy minima at 𝜉12 = 23.75 Å, and is unstable in the closed state.
However, there are differences between these 1D PMFs and the 1D projections shown
in Fig. 4-2. For glutamate-bound mGluR, the open state minimum observed in the
2D PMFs near ∼28 Å is absent. In apo mGluR3, the closed state is substantially
destabilized compared to the 2D simulations, 𝑊 (𝜉1, 𝜉2) =∼ 1.0 kcal/mol) in 2D, and
𝑊 (𝜉12) =∼ 4.5 kcal/mol in 1D.
4.2.2 Dimer mGluR3 PMFs
Next, we computed PMFs for one mGluR3 LBD in the presence of its dimer part-
ner, both in the inactive state and active state. The active and inactive dimer poses
are each associated with a particular structure Fig. 4-5. The inactive state has a
dimer interface between the LBD upper lobes (Fig. 4-5, right), and the transition
to the active state is characterized by the formation of a dimer interface between the
lower LBD lobes (Fig. 4-5, left). For the PMFs of mGluR dimer LBDs, the order
parameters here are identical to those presented in the previous section with mGluR3
monomers, the only difference being that now these calculations are performed with
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the dimer partner present. For these calculations, both subunits are bound to glu-
tamate, and the dimer partner not subject to umbrella sampling is constrained to
a closed position (𝜉1, 𝜉2 = 13.0, 16.5 Å). In the active state, there is a global free
energy minimum at (𝜉1, 𝜉2 = 13.0, 16.5 Å), and in the inactive state the global free
energy minima is at (𝜉1, 𝜉2 = 13.7, 16.5 Å) Fig. 4-6. Both PMFs for the active and
inactive states possess one free energy minimum, with monotonically increasing free
energy away from the free energy minima. The active state, however, has a much
steeper free energy gradient compared to the inactive state which are readily seen in
the 1D projections in Fig. 4-6 right. Error analysis for dimer calculations are shown
in Fig. 4-7.
Interestingly, glutamate-bound monomer LBD is bistable, but the glutamate-
bound dimers are not. In the active state, this makes sense: extensive contacts
between lobes mutually prevent LBD opening. For inactive state dimer, however, it
is less clear why this is the case as there are no obvious steric blocks that prevent
one LBD opening much like in the monomer. This suggests cooperativity between
subunits which as been recently observed in vitro [16], and suggests some mechanism
of allostery between subunits.
4.2.3 Free energy change between open and closed states
Calculating a Δ𝐺 between open and closed states would be a convenient way to
summarize differences between PMFs. To do this, we differentiate between open and
closed states by defining a pair of residues on the top and bottom lobes that form a
bottleneck along a tunnel between bulk solvent and the binding pocket. These residues
would restrict entry of glutamate to the binding pocket if the distance between the
bottleneck residues is smaller than some threshold value. The LBD is defined as
closed if the distance between the bottleneck residues is smaller than this value, and
open if the distance is greater than this value. The CAVER program was used to
identify bottleneck residue in mGluR3 [17]. In mGluR, the bottleneck was defined as
the distance between 𝐶𝛾 of arginine 40 and 𝐶𝛽 of serine 254. In a given conformation
of mGluR, if the bottleneck distance is less than 12 Å, the LBD is closed, and open
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if the bottleneck distance is greater than or equal to 12 Å. 12 Å was chosen based on
the geometry of a glutamate molecule, in accordance with previous results [15].
The relative probability of an mGluR3 LBD occupying an open or closed state is










where 𝑊 (𝜉1, 𝜉2) is the PMF, and the region of integration corresponds to either
(𝜉1, 𝜉2) in which the bottleneck distance ≥12 Å (open) or <12 Å (closed); 𝑘𝐵 is Boltz-
mann’s constant, and 𝑇 is temperature. The conformational free energy difference
between open and closed states is then given by,










In monomer mGluR3, the apo state has a Δ𝐺conf of -1.19 kcal/mol, and the
glutamate-bound LBD has a Δ𝐺conf of -0.60 kcal/mol. This corresponds to a stabi-
lization of the closed state in the glutamate-bound LBD, ΔΔ𝐺conf, of 0.59 kcal/mol,
which is on par with thermal energy. In the dimer system, the active state has a
Δ𝐺conf of 10.31 kcal/mol and in the inactive state Δ𝐺conf is 6.99 kcal/mol. The
closed state is stabilized in the active state by 3.32 kcal/mol compared to the inactive
state. Dimer closed states are significantly stabilized relative to monomer mGluR3,
7.59 kcal/mol for the inactive state and 10.91 kcal/mol for the active state. Plots of
how bottleneck distance scales with (𝜉1, 𝜉2) for monomer and dimer mGluR3 LBDs
are shown in Fig. 4-8. Free energies are summarized in Table 4.1.
4.2.4 Allostery in mGluR dimers
Why are the PMFs for glutamate-bound monomer mGluR3 LBDs different from the
glutamate-bound dimer mGluR3s? In the active pose, there is a straightforward phys-
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ical interpretation: the extensive contact between the lower lobes mutually prevent
cleft opening in each subunit. However, in the inactive pose, the lower lobes are well
separated. There are no obvious steric blocks to prevent LBD opening. One possibil-
ity is allosteric communication between subunits. Allostery involves communication
between distal regions of a protein or protein complex. Here, we perform allosteric
network analysis for the glutamate-bound monomer mGluR3 and inactive mGluR3
dimer. Briefly, proteins are represented as networks of nodes, which individual amino
acids, and edges between nodes, which represent contact between residues. Here, the
𝐶𝛼 atom of each residue is a node, and an edge is drawn between two nodes 𝑖, 𝑗 if any
two atoms belonging to residue 𝑖 is within 5 Å of any atom in residue 𝑗 for at least
75% of the simulation.
To get a quantify for how the dynamics of the dimer and monomer differ on
the residue-level, covariance matrices, 𝐶𝑖𝑗, were computed for both the dimer and
monomer. This calculation will identify patches of residues whose dynamics change
relative to the rest of the protein from one system to another. For the dimer, the
covariance matrix is only generated for the LBD from which the PMF is computed.
Then a difference covariance matrix (i.e. Δ𝐶𝑖𝑗 = 𝐶𝑖𝑗,𝑑𝑖𝑚𝑒𝑟−𝐶𝑖𝑗,𝑚𝑜𝑛𝑜𝑚𝑒𝑟) was computed
to highlight regions of the protein where dynamics differ between the two systems.
There are two clusters of residues where visible differences are observed, referred to
as region 1 and 2 (Fig. 4-9). Region 1 roughly corresponds to residues 95-112, which
is highlighted in red on the structural model in the bottom left of Fig. 4-9. This
loop notably has a disulfide linkage between the two mGluR3 subunits in the dimer,
which likely alters its dynamics relative to the monomer state. This loop is unlikely to
contribute to differences in thermodynamics of LBD opening because it is far removed
from the LBD cleft. Region 2 is smaller than region 1, and corresponds roughly to
residues 200-210. These residues are located on a helix in the lower lobe of the LBD.
This helix is situated on the side of the LBD that faces the other dimer subunit.
We are currently in the process of running more dimer simulations to test the
thermodynamic effect of changing the state of the dimer partner, namely, in the
apo/open states. Additionally, with these results we may identify allosteric networks
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that change from one state to another.
4.2.5 Free energy change of dimer reorientation
To compute the energetics associated with the transition from the inactive to active
state of the LBD, we use a 1D dihedral order parameter (Θ) that describes the state
of the dimer (Fig. 4-10, top). The initial configurations span from Θinactive = 35∘ to
Θactive = 95
∘. Umbrella sampling along this order parameter was used to calculate
a PMF (Fig. 4-10, bottom). The PMF at first glance is not smooth and contains
large error bars, even after more than 5 ns of simulation time per window. The
global free energy minimum is located at Θ = 99.5∘, which is near the edge of the Θ
sampled with umbrella sampling and is also ∼2.5 kcal/mol lower in free energy than
any other region of the PMF. Other than this, qualitatively, the PMF appears to have
two minima separated by a free energy barrier. The minima are near Θ = 35∘ and
Θ = 80∘, although this second minimum could properly extend from Θ = 70∘ − 100∘,
given the large error bars.
4.3 Discussion
To probe the space of accessible conformations for an mGluR LBD, we computed
2D PMFs of apo and glutamate-bound mGluR3 monomer LBDs. Both monomer
LBDs are highly conformationally flexible, with low free energy regions spanning
open and closed conformations. The apo PMF has a slightly less accessible closed
state than the glutamate-bound LBD, which exhibits two-state behavior. To quantify
the difference between the PMFs, we classified conformations into open and closed
states using a cutoff distance value between two bottleneck residues lining a binding
tunnel. The closed state for apo mGluR3 is roughly 0.6 kcal/mol destabilized relative
to glutamate-bound monomer. We also computed monomer mGluR3 PMFs in 1D,
which would be useful in simulations that examine additional degrees of freedom.
The 1D PMFs are similar to the 1D projections of 2D PMFs. However, differences
are observed, such as the discrepancy in the position of the open-state minimum
for glutamate bound mGluR3. This discrepancy is likely explained by the choice of
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initial configurations for umbrella sampling, which were generated along a diagonal
of (𝜉1, 𝜉2). This diagonal along which conformations were selected has a slope equal
to one, but the slope of the 2D PMF corresponding to the pathway that minimizes
the free energy is less than 1, so the initial configurations for open conformations in
the 1D PMF are too far removed from the 2D minimum. This could be avoided in
future studies by increasing the sampling time, which is currently insufficient (0.8
ns/window), or with a better choice of initial configurations. In apo mGluR3, the
closed state is substantially destabilized in the 1D simulations compared to the 2D
simulations. It’s unclear why this discrepancy exists, but it possibly reflects normal
variance in results (the two 1D plots are just outside of ∼ 1 standard deviation of
each other in the closed states).
We also computed 2D PMFs for mGluR3 LBDs in the presence of their dimer
partners in active and inactive dimer states. The active state stabilizes closed cleft
LBD states compared to the inactive state, which is likely explained by extensive
dimer contacts between the upper and lower lobes in the active state, which prevent
LBD cleft opening. For both the active and inactive states, the closed LBD state is
significantly stabilized compared to monomer mGluR3. This makes sense in the active
form, where the lower lobes likely mutually reinforce closed states. In the inactive
state, however, their is nothing obviously blocking LBD opening. We found that a
helix in the lower lobe changes its dynamics in the dimer states vs the monomer
state. Notably, this helix is situated on the side of the LBD that faces the other
dimer subunit. One intriguing possibility explaining this change is an allosteric signal
from the dimer partner, although future will will have to test this. Cooperativity
has been documented in mGluRs [16]. Importantly, the input data for this analysis
is unweighted. Future work should appropriately Boltzmann-weight input data for
a more accurate representation of dynamics. Additionally, it would be interesting
to examine the change in dynamics in particular regions of the PMF, perhaps near
the closed state. Future work should also examine the inactive state PMF in various
states of the LBD dimer partner. especially apo and/or open states. To look at
allostery, dynamical network analysis can be readily performed much like that done
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in [18], and is available as an analysis package in VMD.
To calculate the PMF along a pathway corresponding to the transition between
inactive and active states of the dimer, we defined a 1D dihedral order parameter, Θ,
to describe the state of the dimer. The resulting PMF is noisy with large errors. The
source of the large error bars is unknown. The system has been extensively sampled (5
ns/window), but it is possible convergence will happen with more sampling. It is also
possible an additional order parameter is required to sample this space. Generally
there appears to be two regions of lower free energy separated by a free energy barrier.
This system has been extensively sampled (5 ns/window) and does not appear to be
closer to convergence than at 4 or 3 ns/window (data not shown). Future work here
should focus on potentially revisiting the order parameters for this system, or perhaps
adjusting the force constant.
4.4 Methods
4.4.1 Molecular dynamics simulation
MD simulations were carried out in the CHARMM [19] and NAMD [20] programs with
TIP3 explicit water model [21]. PDB structure 2E4U was used as a representative
mGluR 3 structure, with the CRD removed [22]. 2E4U is in an inactive pose. To
model the active state, the 2E4U LBDs were structurally aligned to the mGluR3 LBDs
in 3SM9, which is an active pose. Residues not modeled in the crystal structure were
built using the MODELLER [23] program. The disulfide bridge between cysteine
103 of each subunit was built into our model [24]. Crystallographic waters buried
within the LBD were maintained, whereas waters outside the LBD were deleted.
Orthorhombic water boxes (monomer: 110 × 80 × 65 Å3, dimer-active: 116 × 87 ×
87 Å3, and dimer-inactive 118 × 98 × 83 Å3) with 150 mM NaCl were used for all
simulations, with an offset to balance protein charge and to set the total system charge
to 0. Following equilibration in NVT ensemble, production runs were carried out in
the NPT, with P = 1 atm and T = 300 K [25]. Long range electrostatic interactions
were computed with the Ewald method [26]. In simulations with a glutamate ligand,
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the 𝛾 carboxyl group was restrained with a half-harmonic potential to the guanidine
nitrogen atoms of arginine 44. The force constant to keep glutamate tethered to
arginine 44 was set to 2 kcal/mol/Å if the ligand drifted more than 3.2 Å from the
arginine 44.
4.4.2 Umbrella sampling
Umbrella sampling of LBD opening was implemented along 2 order parameters. The
first order parameter, 𝜉1, is the distance between the center-of-masses of amino acids
126-128 and 254-256, and the second, 𝜉2 between the center-of-masses of amino acids
364-366 and 283-285. The 1D Umbrella sampling was done by performed by an
order parameter between the center-of-masses of residues 126-128 and 364-366 in the
top lobe and 254-256 and 283-285 in the bottom lobe. 190 umbrella windows were
generated along the order-parameters for the 2D calculations and each was run for
2.2 ns/window in glutamate-bound mGluR3 monomer, and 1.4 ns/window for apo
mGluR monomer. 20 windows were generated for the 1D calculations, and production
runs were carried out for 0.8 ns/window for both apo and glutamate-bound mGluR3.
Unbiasing and free energy calculations were carried out with the weighted histogram
analysis method (WHAM) [27].
For simulations of of the dimer, umbrella sampling was performed with one LBD.
It’s dimer partner was restrained to a closed conformation, ((𝜉1, 𝜉2) = (14, 17 Å))
with a force constant of 2 kcal/mol/Å. The windows for umbrella sampling are the
same as in the monomer (above). Umbrella sampling was carried out for 1 ns/window
in the active state, and 1.6 ns/window in the inactive state.
To compute the PMF along the pathway corresponding to the dimer interface
transition between the inactive and active states, 70 intermediate states were gen-
erated with a linear interpolation morph. Umbrella sampling was conducted along
a 1D order parameter corresponding to a pseudo-dihedral angle (Θ) describing the
dimeric state. The dihedral angle is defined between 1) residues 84-87 of subunit A,
2) residues 134-137 of subunit A, 3) residues 134-137 of subunit B, and 4) residues
84-87 of subunit B. The initial configuration along this pathway ranges from Θ =
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30∘ − 100∘. Force constants for the umbrella windows were set to 2 kcal/mol/deg2.
Each window was equilibrated for 3.0 ns, with 5.4 ns per window in production runes
(108 ns total). PMFs were computed with WHAM.
4.4.3 Covariance matrix calculations
The covariance matrix is given by,
𝐶𝑖𝑗 = ⟨𝑥𝑖 − ?̄?𝑖⟩⟨𝑥𝑗 − ?̄?𝑗⟩ (4.4)
where ?̄?𝑖 is the mean position of the ith atom and ⟨·⟩ represents a mean value.
For covariance matrix calculations of mGluR3, residues were represented by their
𝐶𝛼 atoms. The covariance matrices were generated using the carma program [28].
Unweighted DCD files from umbrella sampling production runs were used as input
into carma.
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Fig. 4-1: mGluR3 order parameters. 𝜉1 and 𝜉2 are the 2D order parameters that
describes the conformational state of mGluR LBD cleft in our simulations. 𝜉1 and 𝜉2
each indicate a distance, represented by dashed lines, between the residues shown in
blue spheres.
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Fig. 4-2: Potential of mean force for apo and glu-bound mGluR3 monomer.
A. Glutamate-bound, and B. apo. The 2D plots are left, and 1D projections are right,
where the black line is the mean free energy value, and blue is the standard deviation.
The 1D plots are computed along a hybrid order parameter 𝜉12, where 𝜉12 = (𝜉1 +
𝜉2)/2.
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Fig. 4-3: Standard deviation of monomer 2D PMFs. The standard deviation
of PMFs shown in Fig. 4-2, glutamate-bound mGluR3 is on top, and apo mGluR3
is on bottom.
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Fig. 4-4: PMF of mGluR3 monomer LBD conducted with a 1D order
parameter. 1D PMFs of glutamate-bound top, and apo bottom mGluR3. The
umbrella windows for these simulations were placed along 𝜉12.
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Fig. 4-5: Structure of active and inactive mGluR3 dimer states. Active state
left and inactive state right.
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Fig. 4-6: PMFs of mGluR3 LBD opening in dimer states. Top, active state.
Bottom, inactive state. 2D PMFs are shown on the left, and 1D projections along 𝜉12
are on the right.
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Fig. 4-7: Standard deviation of dimer simulations. Active (top) and inactive
(bottom) mGluR dimers.
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Fig. 4-8: Distance between the residues defining the bottleneck in mGluR3.
The bottleneck distance is defined between 𝐶𝛾 of arginine 40 and 𝐶𝛽 of serine 254. The
contours correspond to the PMF and the color corresponds to the average distance
between the bottleneck residues in a given 0.1× 0.1 Å2 (𝜉1, 𝜉2) window.
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Fig. 4-9: Dynamic differences between monomer and dimer mGluR3 LBDs.
Top, difference covariance matrix (Δ𝐶𝑖𝑗) between glutamate-bound inactive dimer
and monomer LBDs. Regions with altered dynamics are labeled with 1 and 2. The
matrix is symmetric over the dashed line. Bottom, structures of mGluR3 LBD with
regions 1 and 2 with altered dynamics highlighted in red. Region 1, left, corresponds
to a lop on the upper lobe. Region 2, right, corresponds to a helix in the lower lobe.
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Fig. 4-10: PMF of dimer interface reorientation. Top, Atoms defining Θ are









Active - Inactive 3.32
Inactive - Monomer-Glu 7.59
Table 4.1: Values of Δ𝐺𝑐𝑜𝑛𝑓 and ΔΔ𝐺𝑐𝑜𝑛𝑓 of mGluR3 LBDs.
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Chapter 5 - Structural characterization of insect
ionotropic receptor ligand binding domains
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5.1 Background
Insects recognize environmental chemical stimuli with ion channel receptors [1]. The
ionotropic receptors (IRs) are olfactory receptors expressed in chemosensory neurons
in Drosophila, and are homologous to ionotropic glutamate receptors (iGluR) [2]. In
addition to olfaction, some IRs regulate cold avoidance and humidity sensing ( [3,4]).
IRs are probably expressed as hetero tetrameric ion channels, much like iGluRs [5].
The subunits of the tetramer are composed of odor-specific subunits, which bind
odorants, and co-receptor subunits, which are required for receptor assembly and
trafficking [5, 6].
To date, there are no atomic structures of an IR, or its isolated domains. Here, I
describe the construct design and initial expression and purification attempts for the
isolated LBDs of Drosophila IR8a, IR25a, IR75a, and IR84a in E. coli and a bac-
ulovirus insect cell expression system. In E. coli expression systems, IR84a and IR75a
partition to insoluble inclusion bodies, even when tagged with a SUMO solubility
tag [7]. Co-expression of an odor-specific subunit (IR75a) with a co-receptor (IR8a)
was also unsuccessful. Various strategies were employed to re-fold LBDs from inclu-
sion bodies: on-column refolding, step-wise and flash dilution, and dialysis (see [8]).
Generally, re-folding was unsuccessful, but a few promising leads were observed in
the presence of aggregation inhibitors. In insect cell systems, successful expression
is observed for the IR25a LBD, although most protein partitions to inclusion bod-
ies, but some protein partitions to the soluble fraction. Baculovirus expression looks
promising, but more work is necessary. The purpose of this chapter is to serve as
a roadmap of strategies that have been tried to obtain soluble IRs, and to highlight
promising avenues forward.
5.2 Results
5.2.1 Construct design for IR LBD expression in E. coli.
For expression in E. coli systems, constructs were built for two co-receptors subunit
LBDs, IR8a and IR25a, and two odor-specific subunit LBDs, IR84a and IR75a. The
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odor-specific subunits were chosen because there are validated ligands for these recep-
tors. When expressed with the IR8a co-receptor, IR75a is activated by propionic acid
and IR84a by phenylacetaldehyde [5]. LBD sequences were designed using isolated
iGluR LBDs as a template (Fig. 5-1). The S1 and S2 segments were connected by a
glycine-threonine linker analogous to what is typical of iGluR LBD constructs. IR75a
was built with an N-terminal SUMO tag to improve solubility [7]. Sequences for each
of the IR LBDs presented here are available in Table 5.1.
5.2.2 Expression and purification of IR84a LBD in E. coli.
IR84a was expressed in E. coli and purified from the insoluble fraction solubilized in
the denaturant 6 M guanidine hydrochloride (GdnHCl) Fig. 5-2 (see section 3.4).
IR84a expresses exclusively in the insoluble fraction and solubilizes well in 6 M
GdnHCl but not urea (data not shown). Denatured IR84a was purified on a nickel
column and subjected to various refolding strategies. Re-folding on a nickel column
was unsuccessful (Fig. 5-3): when GdnHCl was washed away, followed by an imida-
zole elution buffer, no detectable protein was collected. However, when again washed
with a GdnHCl buffer, and then eluted with a buffer containing both imidazole and
GdnHCl, significant protein is collected. These results suggest that IR84a forms ag-
gregates on the column that are too large to elute. Perhaps this strategy would be
more successful with more dilute protein.
Flash dilution and buffer exchange strategies were also unsuccessful (data not
shown, see section 3.4). Ligands stabilize iGluR LBDs, which tend to aggregate in
their apo forms, so all re-folding attempts were done both in the absence and presence
of the IR84a ligand phenylacetaldehyde, which could help stabilize the LBD. However,
phenylacetaldehyde is water insoluble and great difficulty was encountered working
with phenylacetaldehyde in aqueous solutions. Due to this, further experiments with
isolated IR84a in solution with phenylacetaldehyde were not conducted.
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5.2.3 Expression and purification of SUMO-IR75a and SUMO-
IR8a LBD in E. coli.
SUMO tags improve protein solubility [7]. Failure to express and re-fold IR84a
prompted us to attempt expression of IR75a and IR8a LBDs with a SUMO tag.
Expression of SUMO-IR75a/SUMO-IR8a was carried out in largely the same way as
IR84a (see section 3.4). No detectable protein was present in the soluble fraction,
but a considerable amount was present in the insoluble fraction (Fig. 5-4). Dena-
tured SUMO-IR75a and SUMO-IR8a was purified on a nickel column in a denaturing
buffer.
The denaturing buffer was slowly exchanged for a "stabilizing buffer" containing
10 mM propionic acid (IR75a only) and 1 M L-arginine and 15% glycerol, which
stabilize proteins and prevent aggregation [9, 10]. Both proteins tolerated the stabi-
lization buffer and was then dialyzed into a buffer containing only 5% glycerol and
no l-arginine. At this step, ∼65% of the protein aggregated, which marked an im-
provement over previous attempts to work in solution without GdnHCl, which always
resulted in 100% aggregation. The remaining SUMO-IR8a/SUMO-IR75a was then
incubated with the SUMO-specific protease (SENP), where detectable cutting took
place (Fig. 5-5 for IR75a and Fig. 5-6 for IR8a). However, the protein aggregates
(both uncut and cut with SENP) when dialyzed into solutions not containing any
L-arginine or glycerol (data not shown). These results suggest IR8a and IR75a are
stable in 5% glycerol solutions.
5.2.4 Co-expression of SUMO-IR75a and IR8a LBDs from a
Duet plasmid.
It has been shown that co-receptors subunits stabilize odor-specific subunits in cellular
environments [6]. The LBD layer of assembled IR tetramers are likely dimer-of-dimers
in analogy to iGluRs, and it is possible that isolated LBDs will be stabilized by their
dimer partners; IR LBDs may have aggregation-prone hydrophobic patches where
their dimer partners are likely to bind. We co-expressed IR75a and IR8a from the
128
RSF-Duet1 plasmid. A Western blot indicates unsuccessful expression, with bands
appearing only near 15 kDa, and not near the expected 30 kDa range Fig. 5-7.
Repeated attempts to rectify this issue were not successful.
5.2.5 Expression of IR8a LBD in a baculovirus insect cell ex-
pression system.
Failure to express soluble IR84a, IR75a, and IR8a in E. coli led us to try IR ex-
pression in a baculovirus insect cell expression system. A recombinant bacmid was
generated with the IR8a LBD, and trial expression was carried out in Hi5 and Sf9
cells. Expression was not observed in Sf9 cells (data not shown), but was observed in
Hi5 cells (Fig. 5-8). The Western blot shown in Fig. 5-8 indicates that the majority
of IR8a partitioned to the insoluble fraction, but there is a faint band is visible in the
soluble fraction.
5.3 Discussion
Revealing the atomic structures of IRs will help us to understand the molecular mech-
anism of olfaction in insects as well as the evolutionary history of ionotropic glutamate
receptors. Structures could also aid in the rational design of insect repellents that
target IR proteins. Here, I describe initial attempts to design and express isolated
LBDs for IR8a, IR25a, IR75a, and IR84a in E. coli and a baculovirus insect cell
expression system.
In E. coli, we attempted to express IR84a alone. The protein partitions to the
insoluble fraction, and resists re-folding attempts. Additionally, its ligand, pheny-
lacetaldehyde, is insoluble in water. Due to this, and the fact that iGluR LBDs
are generally unstable in the absence of ligand, future work with isolated IR84a in
aqueous solution is not recommended unless a more soluble ligand is used or IRs are
generally found to be soluble without ligands.
IR8a and IR75a were expressed with N-terminal SUMO tags to enhance solubility.
Similar to IR84a, these proteins partition to the insoluble fraction and resist re-
folding. There was some success preventing aggregation in the presence of l-arginine
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and glycerol, and even successful cutting with the SUMO-specific SENP protease,
but the proteins resisted transfer out of solutions with aggregation inhibitors. Future
work here might work to optimize buffer conditions that stabilize IRs in solutions
with less than 5% glycerol.
IR8a and IR75a were also co-expressed from a Duet vector. Unfortunately, ex-
pression of full proteins was not observed by Western blot. It is possible that both
proteins expressed, do not initially partition to the insoluble fraction, and are sub-
sequently degraded by cellular machinery. The band observed near 15 kDa could
correspond to the SUMO tag.
IR8a was expressed in baculovirus insect cell expression system. A small amount
of protein was observed in the soluble fraction by Western blot. This is a promising
avenue forward for future work. Also of note, all expression trials in insect cells
discussed here were not done using the secretion machinery (i.e. trafficking through
the ER and Golgi body). The IRs are natively shuffled through the secretion system,
and sit exposed in an extracellular environment, so future work might consider using
the honeybee melittin (HBM) secretion signal to create a more native-like IR protein
folding environment.
Future studies might also re-visit construct design. For instance, odor-specific
subunits have N-terminal regions of variable length that might improve solubility.
In addition, because the S1 and S2 regions are discontinuous, the designed linkers
designed here may not be sufficient to form properly folded IR LBDs. It may also be
more feasible to skip isolated LBD expression entirely, and express IRs as full-length
subunits.
5.4 Methods
5.4.1 Expression and purification of IR LBDs in E. coli.
IR84a LBD : The IR84a LBD was cloned into a pET28a vector from a pUC57 vector
(GenScript), with the restriction enzymes Nde1 and EcoRI. Expression of IR84a was
carried out in Rosetta(DE3) Competent Cells (MilliporeSigma). 1 L Terrific broth
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(TB) was inoculated 20 mL IR84a starter culture and grown to OD600 = 0.7. Cultures
were then cold shocked on ice for 20 minutes, when 400 𝜇L IPTG was added to induce
IR84a expression. Induction was carried out overnight at 4∘C. Cells were harvested
by spinning at 5000 RPM (H4000A 4 x 1 liter rotor, Sorvall) for 30 minutes at 4∘C.
The supernatant was discarded, and cells were suspended in a lysis buffer containing
150 mM NaCl, 20 mM Tris, pH 8. To this, 0.2 mM PMSF 10 𝜇g/ml DNaseI were
added. This mixture was stored on ice for 30 minutes, before cells were lysed in a
microfluidizer. Lysed cells were then spun down at 15,000 RPM (SS-34 rotor, Sorvall)
for 40 minutes at 4∘C. Negligible protein was observed in the soluble fraction.
To clean up the insoluble fraction, it was suspended using a glass tissue homog-
enizer in a buffer containing 100 mM NaCl, 50 mM Tris, pH 8, 1% Triton, 10 mM
DTT, 5 mM EDTA. This suspension was spun down at 15,000 RPM for 40 minutes at
4∘C. The resulting insoluble fraction (insoluble fraction 2) was suspended in a buffer
containing 100 mM NaCl, 50 mM Tris, pH 8, 10 mM DTT, 5 mM EDTA and again
spun down at 15,000 RPM for 40 minutes at 4∘C. The result is insoluble fraction 3,
which was used for purifying and refolding IR LBDs on a nickel column. Purification
of denatured IR LBDs from the nickel column is a standard nickel column purifica-
tion, but in the presence of 6 M GdnHCl. Wash buffer: 6 M GdnHCl, 150 mM NaCl,
50 mM Tris, pH 8, 1 mM DTT, 10 mM imidazole. High Salt Wash buffer: Same
as wash buffer, but with 500 mM NaCl. Elution buffer: Wash buffer with 400 mM
imidazole.
SUMO-IR75a and SUMO-IR8a LBDs : IR75a and IR8a LBDs were cloned into
pSUMO vectors with an N-terminal SUMO tag (provided by Cynthia Wolberger
Laboratory) with the NsiI and XhoI restriction enzymes. Expression was carried out
in an identical way to IR84a (see above).
SUMO-IR8a and IR75a from a RSF-Duet1 vector : SUMO-IR8a and IR75a were
cloned into an RSF-Duet1 vector using BamHI-HF and EcoRI-HF for restriction
enzymes for IR75a at multiple cloning site 1 (MCS1) and NdeI and XhoI for IR8a
at MCS2. Successful insertion was verified using the primers ACYCDuetUP1 and
DuetDOWN1 at MCS1 and DuetUP2 and T7-Term primers at MCS2. Cultures
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grown with kanamycin and chloramphenicol were induced with 400 𝜇L IPTG at OD600
overnight at 4∘C. The lysis procedure was the same as with IR84a (see above). The
sample was run over a nickel column and eluted with 400 𝜇M imidazole. A Western
blot was run on samples.
5.4.2 Refolding IR LBDs from inclusion bodies
Flash dilution: Denatured IR solubilized in 6 M GdnHCl was added drop-wise to a
rapidly spinning, room temperature 700 mL solution of 150 NaCl 50 mM Tris, pH
7, 1 mM DTT, and the 10 mM of LBD ligand (phenylacetaldehyde for IR84a or
propionic acid for IR75a). Solution was then spun at 4000 RPM (Centrifuge 5810
R, Eppendorf) and filtered through 0.22 𝜇M syringe-driven filter unit (Millipore) to
remove aggregates.
Dropwise dilution: Denatured IR (0.5 mg/mL) solubilized in 6 M GdnHCl was
initially dialyzed into a solution 6 M GdnHCl, 100 mM NaCl, 50 mM Tris, pH 8, 10
mM DTT, 5 mM EDTA, which was gradually replaced by a buffer of 150 mM NaCl,
10 mM Tris, pH 8, 1 mM DTT. Solutions were exchanged by a peristaltic pump
(1 mL/min) for 48 hours. Solution was then spun at 4000 RPM (Centrifuge 5810
R, Eppendorf) and filtered through 0.22 𝜇M syringe-driven filter unit (Millipore) to
remove aggregates.
On column refolding: Denatured IR solubilized in 6 M GdnHCl was applied to a
nickel column. The column was washed with a buffer not containing GdnHCl (150
mM NaCl, 10 mM Tris, pH 8, 1 mM DTT, 10 mM propionic acid (for IR75a only))
to promote refolding. An elution buffer with 400 mM imidazole was added to elute
folded protein. This was followed by another wash in denaturing buffer, and then a
denaturing buffer with 400 mM imidazole.
Dialysis into stabilizing buffers: The SUMO-IRs were suspended in a denaturing
buffer (6 M GdnHCl, 100 mM NaCl, 50 mM Tris, pH 7, 10 mM DTT, 5 mM EDTA)
which was substituted by dialysis into a stabilization buffer (1 M L-arginine, 20 mM
HEPES, pH 7, 15% glycerol, 10 mM DTT). The proteins were then dialyzed into
a solution without L-arginine, and lower concentrations of glycerol (150 mM NaCl,
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20 mM HEPES, pH 7, 5% Glycerol, 1 mM DTT). 100 𝜇g SUMO-specific protease
(SENP) was added to separate the IRs from the SUMO tag and incubated for 1 day
at 4∘C and filtered through 0.22 𝜇M syringe-driven filter unit (Millipore) to remove
aggregates. Both cut and uncut samples were dialyzed into solutions not containing
glycerol or l-arginine (150 mM NaCl, 20 mM HEPES, pH 7, 1 mM DTT, 10 mM
propionic acid (IR75a only)).
5.4.3 Expression of the IR8a LBD in a baculovirus insect cell
expression system.
Generating IR recombinant bacmids: IR LBD expression was carried out using the
Bac-to-Bac Baculovirus Expression System (ThermoFisher). IR8a/IR25a/IR75a LBD
genes were cloned into a pFastBacHT-A plasmid. IR-pFastBac plasmids were then
transformed into DH10Bac E. coli which possess the bacmid DNA which will undergo
recombination with IR-pFastBac to transfer IR LBD genes onto the bacmid. Trans-
formed DH10Bac was plated on agar plates with 50 𝜇g/mL kanamycin, 10 𝜇g/mL
tetracycline, 7 𝜇g/mL gentamicin, 100 𝜇g/mL Bluo-gal, and 40 𝜇g/mL IPTG to
select for positive recombination. White colonies indicate successful recombination.
PCR using pUC-M13-F and pUC-M13-R primers was performed to verify positive
recombination (see Table 5.2).
Generating high titer viral stock with recombinant bacmid DNA: 1-5 𝜇g recombi-
nant bacmid DNA (∼500 ng/𝜇L) was transfected into mid-log phase Sf9 insect cells
in a 6-well plate, with ∼1 million cells per plate. Transfected cells were incubated at
27∘C for 96 hours without agitation to allow adhesion. P1 virus was collected from
these samples and spun at 500 𝑔 for 5 min for minutes to remove cellular debris.
500 𝜇L P1 virus was then used to infect 12 mL of mid-log phase Sf9 cells (1-2x106
cells/mL) in a rectangular cell culture flask and incubated without agitation at 27∘C
for 72 hours. P2 virus was collected and spun at 500 g for 5 minutes to remove debris.
P3 stock was generated by infecting 100 mL of Sf9 cells with P2 virus, which again
was incubated at 27∘C for 72 hours and spun at 500 g for 5 minutes to remove debris.
Expression of IR8a into Sf9 and Hi5 insect cells: To express IR8a in Sf9 and Hi5
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insect cells, 20mL P3 stock was added per 1 L of Sf9 and Hi5 cell cultures in mid-log
phase (1-2x106 cells/mL). Hi5 cells were incubated at 27∘C for 48 hours, and Sf9
cells were incubated 27∘C for 72 hours. Cells were spun down at 5000 RPM for 30
minutes and resuspended in lysis buffer containing 300 mM NaCl, 50 mM Tris, pH
8, 5% glycerol, and 0.1% Triton X-100. To this, 0.2 mM PMSF, a protease inhibitor
cocktail tablet (Roche), and 10 𝜇g/ml DNaseI were added. Cells were incubated on
ice for 30 minutes, and then lysed in a microfluidizer, and spun down at 15,000 RPM
at 4∘C for 45 minutes. Sample were taken from the supernatant and insoluble fraction
were for Western blot.
5.4.4 Western blot of his-tagged IRs:
Western blotting was performed on his-tagged IR with a rabbit anti-His antibody
(Cell Signaling Technology). Samples run on SDS-PAGE were transferred to a PVDF
membrane (Bio-Rad) in a transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine,
20% (v/v) methanol, 0.1% Triton X-100) at constant current (350 mA) for 1 hour.
Blocking was carried out in a solution of 5% nonfat dry milk and PBS with 0.1%
Triton X-100 at room temperature for 1 hour. The membrane was incubated with the
primary rabbit anti-his antibody at 4∘C overnight, with constant agitation. Following
a wash, the membrane was then incubated with the HRP-linked anti-Rabbit IgG
secondary antibody (Cell Signaling Technology) for 1 hour at room temperature.
HRP activity was induced by incubating the membrane with SignalFire ECL Reagent
(Cell Signaling Technology) for 1 minute at room temperature.
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Fig. 5-1: IR LBD construct design. Alignment between IR25a and GluN2A
surrounding the LBD segments. In yellow: sequence of the GluN2A LBD as in PDB:
2A5S. In red: sequence included in construct built for IR25a. Residues underlined and
italicized are either known to be or predicted to be inserted in the plasma membrane.
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Fig. 5-2: Purification of denatured IR84a on a nickel column. SDS-PAGE
results of IR84a expressed in E coli. Soluble and insoluble fractions (lanes 1-2 ). Lanes
3-4 show clean up of insoluble fraction through repeated suspension and spin downs.
Lanes 6-8 show purification of denatured IR on a nickel column.
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Fig. 5-3: Refolding IR84a on a nickel column. Denatured IR84a was applied
to a nickel column, lane 2 shows the flow through. Lanes 4-5 show a wash without
GdnHCl, to prompt protein folding, followed by an attempted elution of folded IR84a.
Lanes 6-7 show an additional GdnHCl wash, followed by an elution. This shows that
IR84a likely aggregates on the column, as it is not eluted in the absence of denaturant.
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Fig. 5-4: Purification of denatured SUMO-IR75a on a nickel column. Solu-
ble and insoluble fractions in lanes 1-2. Clean up of the insoluble fraction lanes 3-5.
Purification on a nickel column in lanes 6-8.
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Fig. 5-5: Dialysis of SUMO-IR75a into stabilization buffer and SENP pro-
tease cleavage. Lane 2 shows SUMO-IR75a in a 6 M GdnHCl denaturing buffer.
Lane 3 shows SUMO-IR75a after is has been transferred to a stabilization buffer
containing 5% glycerol. Lane 4 shows successful SUMO-IR75a cleavage by SENP
protease indicated IR75a LBD does not aggregate on its own in solutions containing
glycerol.
139
Fig. 5-6: SENP protease cleavage of SUMO-IR8a. Lane 2 shows uncut SUMO-
IR8. Lane 4 shows cut and filtered SUMO-IR8. The bands labeled IR8a and SUMO
become visible only after cutting with SENP. Lane 5 shows cut SUMO-IR8a after 48
hours, indicated resistance to aggregation over time in 5% glycerol solution.
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Fig. 5-7: Western blot from co-expression of SUMO-IR8a and IR75a from
RSF-Duet1 vector. Western blot from nickel column purification of SUMO-IR8a
and IR75a co-expression. A consistent band near 15 kDa is observed, which is possibly
the SUMO protein. The presence of IR LBDs is not detected (expected band near
45-50 kDa for SUMO-IR8a).
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Fig. 5-8: Expression of IR8a LBD in a baculovirus insect cell expression
system. Anti-his Western blot of IR8a expression. Expression is evident in whole
cell lysate (lane 3 ). Most protein partitions to the insoluble fraction, however there




























Table 5.1: Sequences of IR8a, IR25a, IR75a, and IR84a LBDs.
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Primers to verify pFastBac-HTA inserts:
pUC-M13-F: CCCAGTCACGACGTTGTAAAACG
pUC-M13-R: AGCGGATAACAATTTCACACAGG











Table 5.2: Primers used to clone IR LBDs.
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Chapter 6 - Concluding Remarks
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This dissertation examines the conformational dynamics of various clamshell-like
ligand binding domains (LBDs) primarily using computational and experimental ap-
proaches. The clamshell-like LBDs all belong to a large family of proteins that de-
scend from the periplasmic binding proteins in gram negative bacteria. Generally,
these proteins bind ligands which stabilize a closed cleft conformation over an open
cleft conformation. Structural characterization of these LBDs began over 40 years ago
with the crystal structure of l-arabinose at 5 Å. Since then, this field has remained
remarkably active, and has potential applications to drug discovery, biosensors, op-
togenetics, enzyme and protein design, and more.
Chapter 1 introduces PBPs and the mammalian LBDs for ionotropic gluta-
mate receptors (iGluRs), metabotropic glutamate receptors (mGluRs), and insect
ionotropic receptors (IRs). I review the function, structure, and dynamics of the LBDs
as well as the full receptors in the case of ionotropic glutamate receptors (iGluRs),
metabotropic glutamate receptors (mGluRs), and the ionotropic receptors (IRs). The
iGluRs and mGluRs are required in mammalian central nervous system, and play an
essential role in regulating the transmission of electrical signal between neurons. Un-
covering the structural and dynamical features of these proteins will help to build
a more accurate model of the mammalian synapse. The IRs are olfactory receptors
in insects that are homologous to iGluRs. A structural model of an IR will help to
reveal the mechanism of odor detection in insects, as well as to aid our understanding
of divergent evolutionary pathway of iGluRs and IRs.
Chapter 2 introduces the primary computational method utilized in later chap-
ters. Namely, there is a brief introduction to molecular dynamics simulation and
umbrella sampling, the tool we use to compute PMFs, or free energy landscapes of
LBDs. This chapter also gives a practical overview of how to set up an LBD system
for umbrella sampling using the order parameters we define for most of our systems.
Chapter 3 presents the first PMFs for a kainate receptor LBD. We find that the
apo GluK2 LBD exhibits high conformational flexibility that spans open and closed
conformations. We also find that the glutamate-bound GluK2 LBD is more flexible
than the LBDs of other iGluR subtypes. Mutations that disrupt interactions across
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the binding cleft have a variable effect on closed state stability: one mutation appears
to have no effect at all, while the other has a significant effect. Finally, we show
that theoretical SAXS from our computational ensemble of glutamate-bound GluK2
better fit with experimental results obtained in the presence of saturating glutamate.
Significant effort was spent trying to perform SAXS on apo GluK2, as well as to
grow crystals for X-ray crystallography. Apo GluK2 is prone to aggregation and is
sensitive to X-ray beams. Characterizing apo GluK2 is left to a future member of the
lab. One general question remains: what give rise to the unique properties of iGluR
LBDs? Here we present some analysis looking at bulk and surface electrostatics,
but a more thorough investigation is needed. It is also unclear how these properties
translate to the full length receptor. Future computational studies of kainate receptors
might involve more complicated setups: LBD dimers, ATD-LBD systems, full-length
tetramers.
Chapter 4 presents PMFs for mGluR3, which are the first PMF presented for
any clamshell-like domain descended from the Class I PBPs. We show that mGluR3
monomers are highly flexible, but that flexibility is lost in a dimer system where
both LBDs are glutamate-bound and at least one LBD is constrained closed. This
suggests an allosteric effect of dimerization, and we observed a change in the dynamics
of a single helix in the lower lobe that might account for the change observed in
the PMF. We also present the PMF along an order parameter corresponding to the
transition between inactive and active dimer states. The PMF is noisy and can likely
be improved with either more sampling, tuning the force constant, or a change of
order parameters. Future studies on mGluRs might look at other subtypes, ligand
binding pathways, and systems of the full-length receptor.
Chapter 5 is a first attempt at expressing and purifying IR LBDs. Generally,
the IR LBDs I designed appear to be insoluble. We attempted a wide array of
strategies: different subtypes, refolding from inclusion body, adding a solubilizing
tag, co-expression, and baculovirus insect cell expression. The baculovirus insect cell
expression has some promising results, with a small amount of protein appearing in
the soluble fraction. This result needs to be followed up on in future work. However,
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it might be worth revisiting LBD construct design to see if there is anything that can
be done to improve upon current designs. If soluble LBD is obtained, ligand-binding
assays can be done in addition to structural work. Finally, it might be easier to
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